首页 » 细胞株Cell Lines 103及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net

细胞株Cell Lines 103及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net

  • 价  格:¥19200
  • 货  号:NTCC-CV102
  • 产  地:北京
点击询问我要采购
 竭诚为您服务!
BioVector NTCC典型培养物保藏中心
联系人:Dr.Xu, Biovector NTCC Inc.点击这里给我发消息

电话:+86-010-53513060. 工作QQ:1843439339

邮件:Biovector@163.com

手机:18901268599

地址:北京

已注册
 

细胞株Cell Lines-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心

http://www.biovector.net


ID   SV-E

AC   CVCL_0C27

DR   Cosmic; 2239091

RX   PubMed=7736387;

RX   PubMed=9559344;

RX   PubMed=9815546;

RX   PubMed=10100721;

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SV-HCEC

AC   CVCL_DQ72

SY   SVHCEC

RX   PubMed=9367354;

RX   PubMed=11032886;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   SV-HFO

AC   CVCL_4T85

SY   SVHFO; SV40-transformed Human Fetal Osteoblastic cells

RX   CelloPub=CLPUB00294;

RX   PubMed=8387478;

RX   PubMed=15072557;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SV-HUC-1

AC   CVCL_3798

SY   HUC-1; SV-HUC; SVHUC

DR   BTO; BTO:0003908

DR   CLO; CLO_0009177

DR   ATCC; CRL-9520

DR   BCRC; 60358

DR   BioSample; SAMN03471218

DR   Cosmic; 687554

DR   KCB; KCB 2012112YJ

RX   Patent=US4980290;

RX   PubMed=2822239;

RX   PubMed=2835156;

RX   PubMed=2841047;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 12,13

ST   D16S539: 11

ST   D5S818: 12,14

ST   D7S820: 10,11

ST   TH01: 9,9.3

ST   TPOX: 8,10

ST   vWA: 14

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SV-HUC-2

AC   CVCL_G006

RX   PubMed=2822239;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   SV-HUC/ras-A

AC   CVCL_IP92

SY   SV-HUC/ras clone A; EJ/ras-A

RX   PubMed=1316224;

RX   PubMed=2164447;

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3798 ! SV-HUC-1

SX   Male

CA   Transformed cell line

//

ID   SV-HUC/ras-B

AC   CVCL_IP93

SY   SV-HUC/ras clone B

RX   PubMed=2164447;

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3798 ! SV-HUC-1

SX   Male

CA   Transformed cell line

//

ID   SV-HUC/ras-C

AC   CVCL_IP94

SY   SV-HUC/ras clone C

RX   PubMed=2164447;

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3798 ! SV-HUC-1

SX   Male

CA   Transformed cell line

//

ID   SV-HUC/ras-D

AC   CVCL_IP95

SY   SV-HUC/ras clone D

RX   PubMed=2164447;

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3798 ! SV-HUC-1

SX   Male

CA   Transformed cell line

//

ID   SV-HUC/ras-E

AC   CVCL_IP96

SY   SV-HUC/ras clone E

RX   PubMed=2164447;

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3798 ! SV-HUC-1

SX   Male

CA   Transformed cell line

//

ID   SV-HUC/ras-F

AC   CVCL_IP97

SY   SV-HUC/ras clone F

RX   PubMed=2164447;

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3798 ! SV-HUC-1

SX   Male

CA   Transformed cell line

//

ID   SV-HUC/ras-G

AC   CVCL_IP98

SY   SV-HUC/ras clone G

RX   PubMed=2164447;

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3798 ! SV-HUC-1

SX   Male

CA   Transformed cell line

//

ID   SV-JD

AC   CVCL_H239

SY   SVJD

RX   PubMed=8212552;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Caution: Could be identical to SV6-1 Bam/HFK (CVCL_H240).

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   SV-Mm-11

AC   CVCL_V317

RX   PubMed=217958;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9888; ! Muntiacus muntjak

HI   CVCL_V316 ! Mm-2K

SX   Male

CA   Transformed cell line

//

ID   SV-Mm-12

AC   CVCL_V318

RX   PubMed=217958;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9888; ! Muntiacus muntjak

HI   CVCL_V316 ! Mm-2K

SX   Male

CA   Transformed cell line

//

ID   SV-Mm-12A

AC   CVCL_V319

RX   PubMed=217958;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9888; ! Muntiacus muntjak

HI   CVCL_V318 ! SV-Mm-12

SX   Male

CA   Transformed cell line

//

ID   SV-Mm-13

AC   CVCL_V320

RX   PubMed=217958;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9888; ! Muntiacus muntjak

HI   CVCL_V316 ! Mm-2K

SX   Male

CA   Transformed cell line

//

ID   SV-Mm-21

AC   CVCL_V321

RX   PubMed=217958;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9888; ! Muntiacus muntjak

HI   CVCL_V316 ! Mm-2K

SX   Male

CA   Transformed cell line

//

ID   SV-T2

AC   CVCL_4554

SY   BALB 3T3 SV-T2

DR   CLO; CLO_0009181

DR   CLDB; cl4423

DR   CLDB; cl4424

DR   CLDB; cl4425

DR   ATCC; CCL-163.1

DR   ChEMBL-Cells; CHEMBL3307978

DR   ChEMBL-Targets; CHEMBL612564

DR   ECACC; 90030801

DR   IZSLER; BS CL 106

DR   JCRB; JCRB9099

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: BALB/c.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0184 ! BALB/3T3 clone A31

CA   Transformed cell line

//

ID   SV-TGo

AC   CVCL_T958

RX   PubMed=212573;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   SV/HF-5/39

AC   CVCL_G293

SY   SV/HF-5 Cl39

RX   PubMed=2823105;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_G292 ! HS74

CA   Transformed cell line

//

ID   SV3T3B

AC   CVCL_4311

DR   CLO; CLO_0009166

DR   CLDB; cl4427

DR   ECACC; 85011409

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   SV40 MES 13

AC   CVCL_5368

SY   SV40-MES13; MES-13; MES 13; MES13

DR   CLO; CLO_0009167

DR   ATCC; CRL-1927

DR   BCRC; 60366

DR   GEO; GSE2557

RX   PubMed=2835539;

RX   PubMed=17178593;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=MES-13

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   SV40 OFPAE

AC   CVCL_6G13

SY   SV40-transformed Ovine FetoPlacental Artery Endothelial cells

RX   PubMed=17005940;

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pRNS-1].

OX   NCBI_TaxID=9940; ! Ovis aries

CA   Transformed cell line

//

ID   SV40-tsA58 OMCD

AC   CVCL_6B06

RX   PubMed=8852699;

RX   PubMed=11520047;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Miscellaneous: As no precise cell line name was given in the paper, we assigned the name based on the immortalization technique and the primary cell type name.

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   SV40-tsA58 S1

AC   CVCL_6B07

RX   PubMed=8595391;

RX   PubMed=8852699;

RX   PubMed=9224657;

RX   PubMed=11520047;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Miscellaneous: As no precise cell line name was given in the paper, we assigned the name based on the immortalization technique and the primary cell type name.

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   SV40-tsA58 S3

AC   CVCL_6B08

RX   PubMed=8852699;

RX   PubMed=11520047;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Miscellaneous: As no precise cell line name was given in the paper, we assigned the name based on the immortalization technique and the primary cell type name.

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   SV40LT-SMC Clone HEP-SA

AC   CVCL_6454

DR   CLO; CLO_0009169

DR   ATCC; CRL-2018

DR   BCRC; 60523

RX   PubMed=2154504;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: Sprague-Dawley.

OX   NCBI_TaxID=10116; ! Rattus norvegicus

CA   Transformed cell line

//

ID   SV40T-DPC

AC   CVCL_T950

SY   SV40T-transformed Dermal Papilla Cells

RX   PubMed=17560084;

CC   Characteristics: SV40-transformed but with a finite life span.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Finite cell line

//

ID   SV40T-hTERT-DPC

AC   CVCL_T951

RX   PubMed=21871174;

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_T950 ! SV40T-DPC

CA   Telomerase immortalized cell line

//

ID   SV6

AC   CVCL_0E03

SY   SPAML/SV6

DR   ATCC; CRL-2427

RX   PubMed=11485907;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Discontinued: ATCC; CRL-2427; true.

DI   NCIt; C3888; Renal angiomyolipoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SV6-1 Bam/HFK

AC   CVCL_H240

SY   SV6-1 BAM/HFK; SV61 Bam/HFK

RX   PubMed=2423124;

RX   PubMed=2447927;

RX   PubMed=6191883;

RX   PubMed=6319304;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Caution: Could be identical to SV-JD (CVCL_H239).

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Transformed cell line

//

ID   SV63

AC   CVCL_F768

DR   CLO; CLO_0009170

DR   ATCC; HB-8766

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   SV68c-IS

AC   CVCL_M084

SY   SV68 c-IS

DR   BTO; BTO:0003529

RX   PubMed=11123759;

RX   PubMed=17760834;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: ICR.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   SV7

AC   CVCL_J654

SY   SPAML/SV7

DR   BTO; BTO:0004391

DR   ATCC; CRL-2428

RX   PubMed=11485907;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Discontinued: ATCC; CRL-2428; true.

DI   NCIt; C3888; Renal angiomyolipoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SV7tert

AC   CVCL_3602

SY   SV7 tert

DR   BTO; BTO:0004390

DR   CLO; CLO_0009171

DR   ATCC; CRL-2461

DR   BioSample; SAMN03471581

RX   PubMed=11485907;

RX   PubMed=17592550;

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8

ST   D16S539: 9,11

ST   D5S818: 11,13

ST   D7S820: 11

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C3888; Renal angiomyolipoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_J654 ! SV7

SX   Female

CA   Telomerase immortalized cell line

//

ID   SV7tert PDGF

AC   CVCL_0F39

DR   ATCC; CRL-4007

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Discontinued: ATCC; CRL-4007; true.

DI   NCIt; C3888; Renal angiomyolipoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3602 ! SV7tert

SX   Female

CA   Telomerase immortalized cell line

//

ID   SV7tert PDGFtu1

AC   CVCL_C573

SY   SV7tert PDGF tumor-1

DR   ATCC; CRL-4008

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8

ST   D16S539: 9,11

ST   D5S818: 11,13

ST   D7S820: 11

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C3888; Renal angiomyolipoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3602 ! SV7tert

SX   Female

CA   Telomerase immortalized cell line

//

ID   SV7tert PDGFtu2

AC   CVCL_0F40

SY   SV7tert PDGF tumor-2

DR   ATCC; CRL-4009

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Discontinued: ATCC; CRL-4009; true.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8

ST   D16S539: 9,11

ST   D5S818: 11,13

ST   D7S820: 11

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 17,18

DI   NCIt; C3888; Renal angiomyolipoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_3602 ! SV7tert

SX   Female

CA   Telomerase immortalized cell line

//

ID   SV80

AC   CVCL_0541

SY   SV-80; SV 80

DR   MCCL; MCC:0000442

DR   ATCC; CRL-7725

DR   CLS; 300345/p623_SV-80

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Discontinued: ATCC; CRL-7725; true.

ST   Source(s): CLS

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12

ST   D16S539: 9,13

ST   D18S51: 15,20

ST   D21S11: 28,30

ST   D3S1358: 16

ST   D5S818: 12

ST   D7S820: 10

ST   D8S1179: 11,15

ST   FGA: 21,27

ST   Penta D: 9

ST   Penta E: 11,12

ST   TH01: 9

ST   TPOX: 10,11

ST   vWA: 16

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SVCT

AC   CVCL_2718

DR   CLO; CLO_0009172

DR   ECACC; 94122105

DR   Ximbio; 152701

RX   PubMed=2423124;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SVCT-MI2

AC   CVCL_2719

SY   SVCT-M12

DR   ECACC; 98031105

DR   Ximbio; 152596

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transfected with: HGNC; 5173; HRAS (with V-12).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_2718 ! SVCT

SX   Female

CA   Transformed cell line

//

ID   SVD-2

AC   CVCL_6E59

RX   PubMed=6190988;

CC   Characteristics: Transfected with two copies of the genome of a human papillomavirus type 1 virus.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV6-1].

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SVDC

AC   CVCL_6C14

RX   PubMed=15598888;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   SVE3

AC   CVCL_Y908

RX   PubMed=2478401;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SVEC4-10

AC   CVCL_4393

DR   BTO; BTO:0002826

DR   CLO; CLO_0009173

DR   ATCC; CRL-2181

DR   BCRC; 60220

RX   PubMed=2153170;

RX   PubMed=8496612;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C3H/HeJ.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Male

CA   Transformed cell line

//

ID   SVEC4-10EE2

AC   CVCL_4394

DR   CLO; CLO_0009174

DR   ATCC; CRL-2167

RX   PubMed=8496612;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C3H/HeJ.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4393 ! SVEC4-10

SX   Male

CA   Transformed cell line

//

ID   SVEC4-10EHR1

AC   CVCL_4395

DR   CLO; CLO_0009175

DR   ATCC; CRL-2161

RX   PubMed=8496612;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C3H/HeJ.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_4393 ! SVEC4-10

SX   Male

CA   Transformed cell line

//

ID   SVG

AC   CVCL_5G14

SY   SV40 immortalized Glial cell

RX   PubMed=2983332;

RX   PubMed=8689028;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SVG p12

AC   CVCL_3797

SY   SVGp12; SVG(P12)

DR   BTO; BTO:0005184

DR   CLO; CLO_0009176

DR   ATCC; CRL-8621

DR   BCRC; 60371

DR   BioSample; SAMN03471204

DR   IZSLER; BS CL 200

RX   Patent=US4707448;

RX   PubMed=24760884;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Caution: Cell line contaminated with BK polyomavirus strain UT (PubMed: 24760884).

ST   Source(s): ATCC

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11,12

ST   D13S317: 8,13,14

ST   D16S539: 10,11,12

ST   D5S818: 11,12,14

ST   D7S820: 10,12,13

ST   TH01: 6,7,9.3

ST   TPOX: 8,10,11

ST   vWA: 15,16,18,19

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5G14 ! SVG

SX   Male

CA   Transformed cell line

//

ID   SVG-A

AC   CVCL_5G13

DR   GEO; GSM189708

DR   GEO; GSM189709

DR   GEO; GSM189710

DR   GEO; GSM189714

DR   GEO; GSM189715

DR   GEO; GSM189716

RX   PubMed=11517388;

RX   PubMed=14517064;

RX   PubMed=17555786;

RX   PubMed=24760884;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Omics: Transcriptome analysis.

CC   Caution: In contrast to SVG p12 (CVCL_3797), this cell line is not contaminated with BK polyomavirus (PubMed: 24760884).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5G14 ! SVG

CA   Transformed cell line

//

ID   SVG-TH

AC   CVCL_5F78

RX   PubMed=8689028;

CC   Transfected with: HGNC; 11782; TH.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5G14 ! SVG

CA   Transformed cell line

//

ID   SVGR2

AC   CVCL_IM78

DR   GEO; GSM189711

DR   GEO; GSM189712

DR   GEO; GSM189713

DR   GEO; GSM189717

DR   GEO; GSM189718

DR   GEO; GSM189719

RX   PubMed=14517064;

RX   PubMed=17555786;

CC   Characteristics: Resistant to human polyomavirus JCV infection.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Omics: Transcriptome analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_5G13 ! SVG-A

CA   Transformed cell line

//

ID   SVI

AC   CVCL_5943

DR   CLS; 400495/p8093_SVI

RX   PubMed=15200416;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   SVK-1

AC   CVCL_D805

SY   Stria Vascularis K-1

RX   CelloPub=CLPUB00246;

RX   PubMed=12382283;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   SVK-2

AC   CVCL_D806

SY   Stria Vascularis K-2

RX   CelloPub=CLPUB00246;

RX   PubMed=12382283;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   SVK14

AC   CVCL_4Z59

SY   SVK-14; SVK 14

RX   PubMed=2423124;

RX   PubMed=6180835;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   SVM84

AC   CVCL_9127

RX   PubMed=3013792;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9888; ! Muntiacus muntjak

HI   CVCL_9126 ! DM87

SX   Male

CA   Transformed cell line

//

ID   SVMC-a

AC   CVCL_6C25

RX   PubMed=16822814;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Conditionally immortalized cell line

//

ID   SVMC-c

AC   CVCL_6C26

RX   PubMed=16822814;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Conditionally immortalized cell line

//

ID   SVMC-E

AC   CVCL_6C27

RX   PubMed=16822814;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

SX   Female

CA   Conditionally immortalized cell line

//

ID   SVNK-1

AC   CVCL_6C28

SY   SVNK 1

RX   PubMed=16845125;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_6C29 ! SVNK-2

OI   CVCL_6C30 ! SVNK-3

OI   CVCL_6C31 ! SVNK-4

OI   CVCL_6C32 ! SVNK-6

OI   CVCL_6C33 ! SVNK-8

OI   CVCL_6C34 ! SVNK-9

OI   CVCL_6C35 ! SVNK-10

SX   Female

CA   Conditionally immortalized cell line

//

ID   SVNK-10

AC   CVCL_6C35

SY   SVNK 10

RX   PubMed=16845125;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_6C28 ! SVNK-1

OI   CVCL_6C29 ! SVNK-2

OI   CVCL_6C30 ! SVNK-3

OI   CVCL_6C31 ! SVNK-4

OI   CVCL_6C32 ! SVNK-6

OI   CVCL_6C33 ! SVNK-8

OI   CVCL_6C34 ! SVNK-9

SX   Female

CA   Conditionally immortalized cell line

//

ID   SVNK-2

AC   CVCL_6C29

SY   SVNK 2

RX   PubMed=16845125;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_6C28 ! SVNK-1

OI   CVCL_6C30 ! SVNK-3

OI   CVCL_6C31 ! SVNK-4

OI   CVCL_6C32 ! SVNK-6

OI   CVCL_6C33 ! SVNK-8

OI   CVCL_6C34 ! SVNK-9

OI   CVCL_6C35 ! SVNK-10

SX   Female

CA   Conditionally immortalized cell line

//

ID   SVNK-3

AC   CVCL_6C30

SY   SVNK 3

RX   PubMed=16845125;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_6C28 ! SVNK-1

OI   CVCL_6C29 ! SVNK-2

OI   CVCL_6C31 ! SVNK-4

OI   CVCL_6C32 ! SVNK-6

OI   CVCL_6C33 ! SVNK-8

OI   CVCL_6C34 ! SVNK-9

OI   CVCL_6C35 ! SVNK-10

SX   Female

CA   Conditionally immortalized cell line

//

ID   SVNK-4

AC   CVCL_6C31

SY   SVNK 4

RX   PubMed=16845125;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_6C28 ! SVNK-1

OI   CVCL_6C29 ! SVNK-2

OI   CVCL_6C30 ! SVNK-3

OI   CVCL_6C32 ! SVNK-6

OI   CVCL_6C33 ! SVNK-8

OI   CVCL_6C34 ! SVNK-9

OI   CVCL_6C35 ! SVNK-10

SX   Female

CA   Conditionally immortalized cell line

//

ID   SVNK-6

AC   CVCL_6C32

SY   SVNK 6

RX   PubMed=16845125;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_6C28 ! SVNK-1

OI   CVCL_6C29 ! SVNK-2

OI   CVCL_6C30 ! SVNK-3

OI   CVCL_6C31 ! SVNK-4

OI   CVCL_6C33 ! SVNK-8

OI   CVCL_6C34 ! SVNK-9

OI   CVCL_6C35 ! SVNK-10

SX   Female

CA   Conditionally immortalized cell line

//

ID   SVNK-8

AC   CVCL_6C33

SY   SVNK 8

RX   PubMed=16845125;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_6C28 ! SVNK-1

OI   CVCL_6C29 ! SVNK-2

OI   CVCL_6C30 ! SVNK-3

OI   CVCL_6C31 ! SVNK-4

OI   CVCL_6C32 ! SVNK-6

OI   CVCL_6C34 ! SVNK-9

OI   CVCL_6C35 ! SVNK-10

SX   Female

CA   Conditionally immortalized cell line

//

ID   SVNK-9

AC   CVCL_6C34

SY   SVNK 9

RX   PubMed=16845125;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_6C28 ! SVNK-1

OI   CVCL_6C29 ! SVNK-2

OI   CVCL_6C30 ! SVNK-3

OI   CVCL_6C31 ! SVNK-4

OI   CVCL_6C32 ! SVNK-6

OI   CVCL_6C33 ! SVNK-8

OI   CVCL_6C35 ! SVNK-10

SX   Female

CA   Conditionally immortalized cell line

//

ID   SVOG-3e

AC   CVCL_IN98

SY   SVOG3e

DR   BTO; BTO:0005892

RX   PubMed=26408257;

CC   Transfected with: HGNC; 11730; TERT.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SVOG-4m

AC   CVCL_E241

SY   SVOG-4M

RX   PubMed=8832577;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_E242 ! SVOG-4o

SX   Female

CA   Transformed cell line

//

ID   SVOG-4o

AC   CVCL_E242

SY   SVOG-4O

RX   PubMed=8832577;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_E241 ! SVOG-4m

SX   Female

CA   Transformed cell line

//

ID   SVpgC2a

AC   CVCL_DG34

DR   GEO; GSM298193

DR   GEO; GSM190619

DR   GEO; GSM190620

DR   GEO; GSM966935

DR   GEO; GSM966936

DR   GEO; GSM966937

RX   CelloPub=CLPUB00346;

RX   PubMed=7586160;

RX   PubMed=11377230;

RX   PubMed=15651925;

RX   PubMed=18186669;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Transformed cell line

//

ID   SVpgC2a-FOXM1B

AC   CVCL_DH25

DR   GEO; GSM298194

RX   PubMed=19287496;

CC   Transfected with: HGNC; 3818; FOXM1 (isoform FoxM1B).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DG34 ! SVpgC2a

SX   Female

CA   Transformed cell line

//

ID   SVpgC2a-FOXM1B/SVFN1

AC   CVCL_DH26

SY   SVFN1

DR   GEO; GSM298195

RX   PubMed=19287496;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Omics: SNP array analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DH25 ! SVpgC2a-FOXM1B

SX   Female

CA   Transformed cell line

//

ID   SVpgC2a-FOXM1B/SVFN2

AC   CVCL_DH27

SY   SVFN2

DR   GEO; GSM298196

RX   PubMed=19287496;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Omics: SNP array analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DH25 ! SVpgC2a-FOXM1B

SX   Female

CA   Transformed cell line

//

ID   SVpgC2a-FOXM1B/SVFN3

AC   CVCL_DH28

SY   SVFN3

DR   GEO; GSM298197

RX   PubMed=19287496;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Omics: SNP array analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DH25 ! SVpgC2a-FOXM1B

SX   Female

CA   Transformed cell line

//

ID   SVpgC2a-FOXM1B/SVFN4

AC   CVCL_DH29

SY   SVFN4

DR   GEO; GSM298198

RX   PubMed=19287496;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Omics: SNP array analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DH25 ! SVpgC2a-FOXM1B

SX   Female

CA   Transformed cell line

//

ID   SVpgC2a-FOXM1B/SVFN5

AC   CVCL_DH30

SY   SVFN5

DR   GEO; GSM298199

RX   PubMed=19287496;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Omics: SNP array analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DH25 ! SVpgC2a-FOXM1B

SX   Female

CA   Transformed cell line

//

ID   SVpgC2a-FOXM1B/SVFN6

AC   CVCL_DH31

SY   SVFN6

DR   GEO; GSM298200

RX   PubMed=19287496;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Omics: SNP array analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DH25 ! SVpgC2a-FOXM1B

SX   Female

CA   Transformed cell line

//

ID   SVpgC2a-FOXM1B/SVFN7

AC   CVCL_DH32

SY   SVFN7

DR   GEO; GSM298201

RX   PubMed=19287496;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Omics: SNP array analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DH25 ! SVpgC2a-FOXM1B

SX   Female

CA   Transformed cell line

//

ID   SVpgC2a-FOXM1B/SVFN8

AC   CVCL_DH33

SY   SVFN8

DR   GEO; GSM298202

RX   PubMed=19287496;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Omics: SNP array analysis.

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_DH25 ! SVpgC2a-FOXM1B

SX   Female

CA   Transformed cell line

//

ID   SVR

AC   CVCL_6455

SY   SVEN 1 ras

DR   CLO; CLO_0009178

DR   ATCC; CRL-2280

DR   BCRC; 60219

DR   ChEMBL-Cells; CHEMBL3307724

DR   ChEMBL-Targets; CHEMBL614869

DR   JCRB; NIHS0317

RX   PubMed=9023347;

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-127.html

CC   Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Discontinued: JCRB; NIHS0317; true.

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6502 ! MS1

CA   Transformed cell line

//

ID   SVR A221a

AC   CVCL_6456

SY   SVRA221a

DR   CLO; CLO_0009179

DR   ATCC; CRL-2386

DR   JCRB; NIHS0316

RX   PubMed=11106566;

CC   Transfected with: MGI; MGI:1346866; Map2k1 (with A-222).

CC   Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Discontinued: JCRB; NIHS0316; true.

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6455 ! SVR

CA   Transformed cell line

//

ID   SVR bag4

AC   CVCL_6457

SY   SVRbag4

DR   CLO; CLO_0009180

DR   ATCC; CRL-2387

RX   PubMed=11106566;

CC   Transfected with: UniProtKB; P00722; E.coli lacZ.

CC   Transfected with: UniProtKB; P01115; Harvey murine sarcoma virus H-Ras (V-Ha-ras).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

CC   Breed/subspecies: C57BL/6.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_6455 ! SVR

CA   Transformed cell line

//

ID   SVS24

AC   CVCL_6A93

SY   SVS 24

RX   PubMed=9281449;

RX   PubMed=11520047;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   SVS30

AC   CVCL_6A94

SY   SVS 30

RX   PubMed=9281449;

RX   PubMed=11520047;

RX   PubMed=17233813;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].

CC   Breed/subspecies: C57BL/6 SV40-tsA58 transgenic.

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Conditionally immortalized cell line

//

ID   SVts7-1

AC   CVCL_W844

RX   PubMed=1851674;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_E939 ! TIG-3

SX   Male

CA   Transformed cell line

//

ID   SVts8

AC   CVCL_3173

SY   SVts-8; TIG-3 SVts8

DR   JCRB; JCRB0506.1

RX   PubMed=1851674;

RX   PubMed=9290701;

RX   PubMed=10050041;

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA].

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_E939 ! TIG-3

SX   Male

CA   Transformed cell line

//

ID   SW-8

AC   CVCL_IR35

RX   PubMed=3745952;

RX   PubMed=6095297;

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Finite cell line

//

ID   SW-OH1

AC   CVCL_S868

RX   PubMed=12904596;

DI   NCIt; C6586; Extrarenal rhabdoid tumor

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SW10

AC   CVCL_6458

DR   CLO; CLO_0009207

DR   ATCC; CRL-2766

DR   BCRC; 60550

RX   PubMed=12210843;

CC   Characteristics: At the permissive temperature (33 Celsius) proliferates. Does not proliferate at the restrictive temperature (37 Celsius).

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line

//

ID   SW1007

AC   CVCL_1E30

SY   SW-1007; SW 1007

RX   PubMed=327080;

RX   PubMed=6244232;

RX   PubMed=6935474;

RX   PubMed=7459858;

CC   From: Scott and White Clinic; Temple; Texas; USA.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SW1016

AC   CVCL_1E29

SY   SW-1016; SW 1016

RX   PubMed=327080;

CC   From: Scott and White Clinic; Temple; Texas; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SW1045

AC   CVCL_7164

SY   SW-1045; SW 1045

CC   From: Scott and White Clinic; Temple; Texas; USA.

DI   NCIt; C3400; Synovial sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SW1083

AC   CVCL_L215

SY   SW-1083; SW 1083

RX   PubMed=1000501;

RX   PubMed=1778766;

CC   From: Scott and White Clinic; Temple; Texas; USA.

DI   NCIt; C9383; Rectal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SW1088

AC   CVCL_1715

SY   SW-1088; SW 1088

DR   BTO; BTO:0000296

DR   CLO; CLO_0009182

DR   EFO; EFO_0002358

DR   ATCC; HTB-12

DR   BioSample; SAMN03471100

DR   CCLE; SW1088_CENTRAL_NERVOUS_SYSTEM

DR   ChEMBL-Cells; CHEMBL3307573

DR   ChEMBL-Targets; CHEMBL614243

DR   Cosmic; 687584

DR   Cosmic; 897442

DR   Cosmic; 909745

DR   Cosmic; 1036335

DR   Cosmic; 2367550

DR   Cosmic-CLP; 909745

DR   GDSC; 909745

DR   GEO; GSM887663

DR   GEO; GSM888755

DR   GEO; GSM1374914

DR   GEO; GSM1670495

DR   IGRhCellID; SW1088

DR   IZSLER; BS TCL 129

RX   PubMed=327080;

RX   PubMed=6935474;

RX   PubMed=7459858;

RX   PubMed=11414198;

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: PTEN genetic alteration cell panel (ATCC TCP-1030).

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP

ST   Amelogenin: X,Y

ST   CSF1PO: 10,12

ST   D13S317: 12

ST   D16S539: 12,13

ST   D5S818: 11

ST   D7S820: 9

ST   TH01: 7,9.3

ST   TPOX: 8

ST   vWA: 16,17

DI   NCIt; C60781; Astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SW1116

AC   CVCL_0544

SY   SW-1116; SW 1116

DR   BTO; BTO:0001599

DR   CLO; CLO_0009183

DR   CLO; CLO_0009208

DR   EFO; EFO_0002359

DR   MCCL; MCC:0000445

DR   CLDB; cl4429

DR   ATCC; CCL-233

DR   BCRC; 60307

DR   BioSample; SAMN03473185

DR   CCLE; SW1116_LARGE_INTESTINE

DR   ChEMBL-Cells; CHEMBL3308495

DR   ChEMBL-Targets; CHEMBL614942

DR   CLS; 300348/p594_SW-1116

DR   Cosmic; 711271

DR   Cosmic; 719678

DR   Cosmic; 724847

DR   Cosmic; 733171

DR   Cosmic; 887241

DR   Cosmic; 889526

DR   Cosmic; 909746

DR   Cosmic; 948834

DR   Cosmic; 1122331

DR   Cosmic; 1187320

DR   Cosmic; 1223147

DR   Cosmic; 1310939

DR   Cosmic; 1312312

DR   Cosmic; 1479569

DR   Cosmic; 1609499

DR   Cosmic; 1676732

DR   Cosmic; 1805266

DR   Cosmic; 1995649

DR   Cosmic; 2267317

DR   Cosmic; 2302012

DR   Cosmic; 2433753

DR   Cosmic-CLP; 909746

DR   ECACC; 87071006

DR   GDSC; 909746

DR   GEO; GSM206546

DR   GEO; GSM513920

DR   GEO; GSM514307

DR   GEO; GSM741267

DR   GEO; GSM784013

DR   GEO; GSM827441

DR   GEO; GSM887664

DR   GEO; GSM888756

DR   GEO; GSM1346887

DR   GEO; GSM1374915

DR   GEO; GSM1374916

DR   GEO; GSM1374917

DR   GEO; GSM1448114

DR   GEO; GSM1670496

DR   IGRhCellID; SW1116

DR   IZSLER; BS TCL 96

DR   KCLB; 10233

DR   NCBI_Iran; C481

RX   PubMed=1000501;

RX   PubMed=1778766;

RX   PubMed=3349466;

RX   PubMed=6935474;

RX   PubMed=7104989;

RX   PubMed=8422623;

RX   PubMed=9000147;

RX   PubMed=9000572;

RX   PubMed=11414198;

RX   PubMed=11526487;

RX   PubMed=20606684;

RX   PubMed=22460905;

RX   PubMed=24042735;

RX   PubMed=24755471;

RX   PubMed=25485619;

RX   PubMed=25926053;

RX   PubMed=26537799;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Microsatellite instability: Stable (MSS) (PubMed=9000147; PubMed=24042735; PubMed=25926053; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep glycome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'SW116' in Cosmic 1122331 and Cosmic 1676732.

ST   Source(s): ATCC; CLS; Cosmic-CLP; ECACC; KCLB; PubMed=25877200

ST   Amelogenin: X,Y

ST   CSF1PO: 10,11

ST   D13S317: 11,14

ST   D16S539: 9,12

ST   D18S51: 13

ST   D21S11: 28,29

ST   D3S1358: 16

ST   D5S818: 11,12

ST   D7S820: 12 (ATCC; CLS; Cosmic-CLP; KCLB; PubMed=25877200)

ST   D7S820: 11,12 (ECACC)

ST   D8S1179: 10,11

ST   FGA: 21,22

ST   Penta D: 11,13

ST   Penta E: 10,12

ST   TH01: 6 (ATCC; CLS; Cosmic-CLP; ECACC; PubMed=25877200)

ST   TH01: 7 (KCLB)

ST   TPOX: 8,11

ST   vWA: 14,19

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SW1222

AC   CVCL_3886

SY   SW-1222; SW 1222

DR   BTO; BTO:0003105

DR   Cosmic; 876714

DR   Cosmic; 948833

DR   Cosmic; 985653

DR   Cosmic; 986017

DR   Cosmic; 995398

DR   Cosmic; 1043827

DR   Cosmic; 1223148

DR   Cosmic; 1312313

DR   Cosmic; 1479605

DR   Cosmic; 1482523

DR   Cosmic; 1524330

DR   Cosmic; 1803950

DR   Cosmic; 2302013

DR   ECACC; 12022910

DR   GEO; GSM1346888

DR   GEO; GSM1374918

DR   GEO; GSM1448088

DR   Ximbio; 152434

RX   PubMed=1778766;

RX   PubMed=6582512;

RX   PubMed=10737795;

RX   PubMed=20606684;

RX   PubMed=24755471;

RX   PubMed=25926053;

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Microsatellite instability: Stable (MSS) (PubMed=25926053).

CC   Omics: Transcriptome analysis.

ST   Source(s): ECACC

ST   Amelogenin: X,Y

ST   CSF1PO: 11

ST   D13S317: 9,13

ST   D16S539: 9,10

ST   D5S818: 9

ST   D7S820: 10,12

ST   TH01: 7

ST   TPOX: 10

ST   vWA: 18

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SW1271

AC   CVCL_1716

SY   SW-1271; SW 1271

DR   CLO; CLO_0009184

DR   ATCC; CRL-2177

DR   BioSample; SAMN03472877

DR   CCLE; SW1271_LUNG

DR   Cosmic; 701079

DR   Cosmic; 929966

DR   Cosmic; 932919

DR   Cosmic; 1925844

DR   Cosmic-CLP; 1299062

DR   GDSC; 1299062

DR   GEO; GSM169452

DR   GEO; GSM887665

DR   GEO; GSM888757

DR   GEO; GSM986181

DR   GEO; GSM1670497

RX   PubMed=22460905;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: RAS genetic alteration cell panel (ATCC TCP-1031).

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 13

ST   D16S539: 11,12

ST   D18S51: 14

ST   D21S11: 29,31.2

ST   D3S1358: 15

ST   D5S818: 12

ST   D7S820: 9,12

ST   D8S1179: 13,16

ST   FGA: 20

ST   Penta D: 10,12

ST   Penta E: 5,12

ST   TH01: 7,8

ST   TPOX: 8

ST   vWA: 17,20

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SW13

AC   CVCL_0542

SY   SW-13; SW 13; Scott and White No. 13

DR   CLO; CLO_0009185

DR   CLO; CLO_0009209

DR   MCCL; MCC:0000444

DR   CLDB; cl4435

DR   CLDB; cl4436

DR   ATCC; CCL-105

DR   BCRC; 60483

DR   BCRJ; 0300

DR   BioSample; SAMN03472418

DR   BioSample; SAMN03472692

DR   CCRID; 3111C0001CCC000055

DR   CCRID; 3131C0001000700054

DR   ChEMBL-Cells; CHEMBL3308467

DR   ChEMBL-Targets; CHEMBL1075587

DR   CLS; 300349/p565_SW-13

DR   Cosmic; 684683

DR   Cosmic; 909744

DR   Cosmic; 1024274

DR   Cosmic; 1179077

DR   Cosmic; 1622872

DR   Cosmic; 2239456

DR   Cosmic-CLP; 909744

DR   ECACC; 87031801

DR   GDSC; 909744

DR   GEO; GSM827353

DR   GEO; GSM1670498

DR   IZSLER; BS TCL 62

DR   JCRB; JCRB9069

DR   KCB; KCB 200780YJ

DR   KCLB; 10105

DR   TOKU-E; 3228

RX   CelloPub=CLPUB00337;

RX   DOI=10.1007/978-1-4757-1647-4_2;

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=6244232;

RX   PubMed=7459858;

RX   PubMed=11414198;

RX   PubMed=21924324;

RX   PubMed=22266826;

RX   PubMed=27397505;

WW   http://www.cells-talk.com/index.php/page/copelibrary?key=SW-13

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-332.html

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): ATCC; CLS; Cosmic-CLP; ECACC; JCRB; KCLB

ST   Amelogenin: X

ST   CSF1PO: 11,12 (ATCC; Cosmic-CLP; KCLB)

ST   CSF1PO: 12 (CLS; ECACC; JCRB)

ST   D13S317: 9

ST   D16S539: 12

ST   D18S51: 17

ST   D21S11: 31,32.2

ST   D3S1358: 16

ST   D5S818: 12 (ATCC; Cosmic-CLP; ECACC)

ST   D5S818: 11,12 (CLS; JCRB; KCLB)

ST   D7S820: 8,10

ST   D8S1179: 10

ST   FGA: 20

ST   Penta D: 10,13

ST   Penta E: 7,15

ST   TH01: 7,8 (ATCC; CLS; Cosmic-CLP; ECACC; KCLB)

ST   TH01: 7 (JCRB)

ST   TPOX: 8

ST   vWA: 17,19

DI   NCIt; C9325; Adrenal cortex carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SW1318

AC   CVCL_6G40

SY   SW-1318; SW 1318

RX   PubMed=6244232;

RX   PubMed=7459858;

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Derived from metastatic site: Brain.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SW1353

AC   CVCL_0543

SY   SW-1353; SW 1353

DR   BTO; BTO:0002003

DR   CLO; CLO_0009186

DR   CLO; CLO_0009210

DR   EFO; EFO_0002360

DR   MCCL; MCC:0000443

DR   CLDB; cl4957

DR   ATCC; HTB-94

DR   BCRC; 60548

DR   BCRJ; 0382

DR   BioSample; SAMN03472765

DR   CCLE; SW1353_BONE

DR   CCRID; 3131C0001000700128

DR   ChEMBL-Cells; CHEMBL3307462

DR   ChEMBL-Targets; CHEMBL614944

DR   CLS; 300440/p794_SW-1353

DR   Cosmic; 923378

DR   Cosmic; 1602475

DR   Cosmic; 1992321

DR   GEO; GSM887666

DR   GEO; GSM888758

DR   GEO; GSM1670499

DR   GEO; GSM1676319

DR   GEO; GSM1701652

DR   ICLC; HTL99008

DR   IGRhCellID; SW1353

DR   IZSLER; BS TCL 213

DR   NCBI_Iran; C571

DR   TOKU-E; 3213

RX   PubMed=15950496;

RX   PubMed=19787792;

RX   PubMed=22057234;

RX   PubMed=22460905;

RX   PubMed=26351324;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Characteristics: Heterozygous for the IDH2 p.Arg132Ser mutation.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; CLS

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 12,13

ST   D16S539: 11,12

ST   D18S51: 13,17

ST   D21S11: 30,32.2

ST   D3S1358: 15,18

ST   D5S818: 10,11

ST   D7S820: 9,11

ST   D8S1179: 10,11

ST   FGA: 22,23

ST   Penta D: 10,11

ST   Penta E: 12,14

ST   TH01: 6,9

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C2946; Chondrosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SW1370

AC   CVCL_6G41

SY   SW-1370; SW 1370

RX   PubMed=6244232;

CC   From: Scott and White Clinic; Temple; Texas; USA.

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SW1398

AC   CVCL_3885

SY   SW-1398; SW 1398

DR   BTO; BTO:0003746

RX   PubMed=26537799;

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Omics: Deep glycome analysis.

DI   NCIt; C2955; Colorectal carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SW1417

AC   CVCL_1717

SY   SW-1417; SW 1417

DR   BTO; BTO:0001536

DR   CLO; CLO_0009187

DR   CLO; CLO_0009211

DR   EFO; EFO_0002361

DR   CLDB; cl4430

DR   ATCC; CCL-238

DR   BioSample; SAMN03471478

DR   BioSample; SAMN03471575

DR   CCLE; SW1417_LARGE_INTESTINE

DR   ChEMBL-Cells; CHEMBL3308129

DR   ChEMBL-Targets; CHEMBL1075588

DR   Cosmic; 685869

DR   Cosmic; 909747

DR   Cosmic; 948838

DR   Cosmic; 986018

DR   Cosmic; 995413

DR   Cosmic; 1043826

DR   Cosmic; 1090352

DR   Cosmic; 1187321

DR   Cosmic; 1310940

DR   Cosmic; 1312314

DR   Cosmic; 1466825

DR   Cosmic; 1479614

DR   Cosmic; 1609491

DR   Cosmic; 1708405

DR   Cosmic; 1995650

DR   Cosmic; 2302014

DR   Cosmic-CLP; 909747

DR   ECACC; 90102543

DR   GDSC; 909747

DR   GEO; GSM206547

DR   GEO; GSM513921

DR   GEO; GSM514308

DR   GEO; GSM741248

DR   GEO; GSM827354

DR   GEO; GSM887667

DR   GEO; GSM888759

DR   GEO; GSM1346857

DR   GEO; GSM1374919

DR   GEO; GSM1374920

DR   GEO; GSM1448089

DR   GEO; GSM1670500

DR   ICLC; HTL00005

DR   IGRhCellID; SW1417

RX   PubMed=1778766;

RX   PubMed=6935474;

RX   PubMed=7104989;

RX   PubMed=7459858;

RX   PubMed=10737795;

RX   PubMed=11226274;

RX   PubMed=20606684;

RX   PubMed=22460905;

RX   PubMed=24755471;

RX   PubMed=25485619;

RX   PubMed=25926053;

RX   PubMed=25984343;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.pawefish.path.cam.ac.uk/ColonCellLineDescriptions/SW1417.html

WW   http://tcpaportal.org/mclp/

CC   Part of: BRAF genetic alteration cell panel (ATCC TCP-1032).

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Doubling time: 68 hours (PubMed=25984343).

CC   Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Discontinued: ICLC; HTL00005; true.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 10,12 (ATCC; Cosmic-CLP)

ST   D13S317: 12 (PubMed=25877200)

ST   D16S539: 11,12

ST   D18S51: 15

ST   D21S11: 29,32.2,33.2

ST   D3S1358: 15,16

ST   D5S818: 12

ST   D7S820: 9,11

ST   D8S1179: 8

ST   FGA: 23

ST   Penta D: 9,12

ST   Penta E: 8

ST   TH01: 6,8

ST   TPOX: 8,11

ST   vWA: 15,18

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SW1463

AC   CVCL_1718

SY   SW-1463; SW 1463

DR   CLO; CLO_0009188

DR   CLO; CLO_0009212

DR   EFO; EFO_0002362

DR   CLDB; cl4431

DR   ATCC; CCL-234

DR   BCRC; 60521

DR   BioSample; SAMN03471489

DR   CCLE; SW1463_LARGE_INTESTINE

DR   ChEMBL-Cells; CHEMBL3308788

DR   ChEMBL-Targets; CHEMBL1075589

DR   Cosmic; 724851

DR   Cosmic; 909748

DR   Cosmic; 983735

DR   Cosmic; 1071894

DR   Cosmic; 1176595

DR   Cosmic; 1310937

DR   Cosmic; 1708416

DR   Cosmic; 1995651

DR   Cosmic; 2302015

DR   Cosmic-CLP; 909748

DR   ECACC; 90112713

DR   GDSC; 909748

DR   GEO; GSM206548

DR   GEO; GSM513922

DR   GEO; GSM514309

DR   GEO; GSM827417

DR   GEO; GSM887668

DR   GEO; GSM888760

DR   GEO; GSM1346858

DR   GEO; GSM1448113

DR   GEO; GSM1670501

DR   IGRhCellID; SW1463

DR   IZSLER; BS TCL 220

RX   PubMed=7104989;

RX   PubMed=22460905;

RX   PubMed=24755471;

RX   PubMed=25485619;

RX   PubMed=25926053;

RX   PubMed=26537799;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep glycome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; ECACC; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 12,13

ST   D16S539: 11

ST   D18S51: 18

ST   D21S11: 30,31.2

ST   D3S1358: 16,17

ST   D5S818: 13,14

ST   D7S820: 9

ST   D8S1179: 11,15

ST   FGA: 23,28

ST   Penta D: 9,12

ST   Penta E: 17

ST   TH01: 6,7

ST   TPOX: 8,11

ST   vWA: 16

DI   NCIt; C9383; Rectal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SW156

AC   CVCL_1719

SY   SW-156; SW 156

DR   CLO; CLO_0009189

DR   ATCC; CRL-2175

DR   BioSample; SAMN03472558

DR   Cosmic; 687943

DR   Cosmic; 1995652

DR   Cosmic-CLP; 1240220

DR   GDSC; 1240220

DR   GEO; GSM374475

DR   GEO; GSM827270

DR   GEO; GSM1670502

RX   DOI=10.1007/978-1-4757-1647-4_2;

RX   PubMed=833871;

RX   PubMed=6244232;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): ATCC; Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 8

ST   D16S539: 10,12

ST   D5S818: 10,11

ST   D7S820: 11,12

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 18

DI   NCIt; C9385; Renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SW1573

AC   CVCL_1720

SY   SW-1573; SW 1573

DR   BTO; BTO:0003016

DR   CLO; CLO_0009190

DR   EFO; EFO_0002363

DR   ATCC; CRL-2170

DR   BioSample; SAMN03473239

DR   CCLE; SW1573_LUNG

DR   ChEMBL-Cells; CHEMBL3307980

DR   ChEMBL-Targets; CHEMBL612570

DR   Cosmic; 724878

DR   Cosmic; 1017831

DR   Cosmic; 1802305

DR   Cosmic; 2060538

DR   Cosmic-CLP; 724878

DR   GDSC; 724878

DR   GEO; GSM206549

DR   GEO; GSM385526

DR   GEO; GSM385537

DR   GEO; GSM827193

DR   GEO; GSM887669

DR   GEO; GSM888761

DR   GEO; GSM1670503

DR   IGRhCellID; SW1573

RX   PubMed=6935474;

RX   PubMed=22460905;

RX   PubMed=25485619;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.addexbio.com/productdetail?pid=4862

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 11

ST   D16S539: 12,14

ST   D18S51: 16

ST   D21S11: 29

ST   D3S1358: 14,18

ST   D5S818: 12,13

ST   D7S820: 9,11

ST   D8S1179: 11

ST   FGA: 21

ST   Penta D: 9

ST   Penta E: 5,13

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 20

DI   NCIt; C2923; Bronchioloalveolar carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SW161

AC   CVCL_1E52

SY   SW-161; SW 161

RX   DOI=10.1007/978-1-4757-1647-4_2;

RX   PubMed=833871;

CC   From: Scott and White Clinic; Temple; Texas; USA.

DI   NCIt; C2923; Bronchioloalveolar carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SW1710

AC   CVCL_1721

SY   SW-1710; SW 1710

DR   CLO; CLO_0009213

DR   BioSample; SAMN03473594

DR   CCLE; SW1710_URINARY_TRACT

DR   ChEMBL-Cells; CHEMBL3308804

DR   ChEMBL-Targets; CHEMBL1075590

DR   Cosmic; 715750

DR   Cosmic; 760483

DR   Cosmic; 845572

DR   Cosmic; 909749

DR   Cosmic; 1016890

DR   Cosmic; 1046685

DR   Cosmic; 1285129

DR   Cosmic; 1285989

DR   Cosmic; 2037957

DR   Cosmic; 2050463

DR   Cosmic; 2057458

DR   Cosmic; 2444251

DR   Cosmic-CLP; 909749

DR   DSMZ; ACC-426

DR   GDSC; 909749

DR   GEO; GSM763023

DR   GEO; GSM827181

DR   GEO; GSM887670

DR   GEO; GSM888762

DR   GEO; GSM1374921

DR   GEO; GSM1574554

DR   GEO; GSM1670504

RX   PubMed=6744315;

RX   PubMed=6935474;

RX   PubMed=16885334;

RX   PubMed=22460905;

RX   PubMed=24018021;

RX   PubMed=24367658;

RX   PubMed=25997541;

RX   PubMed=26621286;

RX   PubMed=27397505;

CC   Part of: BLA-40 bladder carcinoma cell line panel.

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: UBC-40 urothelial bladder cancer cell line index.

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Doubling time: ~25-32 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): Cosmic-CLP; DSMZ

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 12

ST   D16S539: 8,11

ST   D5S818: 12

ST   D7S820: 8,11

ST   TH01: 7,10 (Cosmic-CLP)

ST   TH01: 7,8,9.3 (DSMZ)

ST   TPOX: 9,11

ST   vWA: 16,17

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SW1736

AC   CVCL_3883

SY   SW-1736; SW 1736

DR   BTO; BTO:0001611

DR   ChEMBL-Cells; CHEMBL3307699

DR   ChEMBL-Targets; CHEMBL614773

DR   CLS; 300453/p463_SW-1736

DR   Cosmic; 886549

DR   Cosmic; 1068627

DR   Cosmic; 1239961

DR   Cosmic; 1280048

DR   Cosmic; 1507375

DR   Cosmic; 1533551

DR   Cosmic; 1536128

DR   Cosmic; 1889006

DR   Cosmic; 2050366

DR   Cosmic; 2054081

DR   Cosmic; 2319853

RX   PubMed=17465858;

RX   PubMed=18713817;

RX   PubMed=21868764;

RX   PubMed=23833040;

CC   From: Scott and White Clinic; Temple; Texas; USA.

ST   Source(s): CLS; PubMed=18713817; PubMed=21868764

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 11,12

ST   D16S539: 11,12

ST   D18S51: 14

ST   D21S11: 29,31

ST   D3S1358: 16,17

ST   D5S818: 12,13

ST   D7S820: 8,11

ST   D8S1179: 13 (CLS)

ST   D8S1179: 13,14 (PubMed=18713817)

ST   FGA: 22

ST   Penta D: 12

ST   Penta E: 11,17

ST   TH01: 6

ST   TPOX: 11

ST   vWA: 16,19

DI   NCIt; C3878; Thyroid gland undifferentiated (anaplastic) carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SW1738

AC   CVCL_A683

SY   SW-1738; SW 1738

RX   PubMed=6744315;

CC   From: Scott and White Clinic; Temple; Texas; USA.

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SW1783

AC   CVCL_1722

SY   SW-1783; SW 1783

DR   CLO; CLO_0009191

DR   EFO; EFO_0002364

DR   ATCC; HTB-13

DR   BioSample; SAMN03472711

DR   CCLE; SW1783_CENTRAL_NERVOUS_SYSTEM

DR   ChEMBL-Cells; CHEMBL3308369

DR   ChEMBL-Targets; CHEMBL1075591

DR   Cosmic; 687585

DR   Cosmic; 897443

DR   Cosmic; 909750

DR   Cosmic; 2367551

DR   Cosmic; 2516039

DR   Cosmic-CLP; 909750

DR   GDSC; 909750

DR   GEO; GSM887671

DR   GEO; GSM888763

DR   GEO; GSM1374922

DR   GEO; GSM1670505

DR   IGRhCellID; SW1783

DR   IZSLER; BS TCL 193

RX   PubMed=11414198;

RX   PubMed=22460905;

RX   PubMed=25984343;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Doubling time: 55 hours (PubMed=25984343).

CC   Microsatellite instability: Instable (MSI-low) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP

ST   Amelogenin: X,Y

ST   CSF1PO: 10,13

ST   D13S317: 9,11

ST   D16S539: 12

ST   D5S818: 12,13 (ATCC)

ST   D5S818: 12 (Cosmic-CLP)

ST   D7S820: 9,13

ST   TH01: 6,8

ST   TPOX: 8,11

ST   vWA: 16,17

DI   NCIt; C9477; Anaplastic astrocytoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SW1990

AC   CVCL_1723

SY   SW-1990; SW 1990

DR   BTO; BTO:0003491

DR   CLO; CLO_0009192

DR   CLO; CLO_0009194

DR   EFO; EFO_0002365

DR   CLDB; cl4438

DR   ATCC; CRL-2172

DR   BioSample; SAMN03472179

DR   CCLE; SW1990_PANCREAS

DR   CGH-DB; 184-1

DR   CGH-DB; 9275-4

DR   ChEMBL-Cells; CHEMBL3308789

DR   ChEMBL-Targets; CHEMBL1075592

DR   Cosmic; 724871

DR   Cosmic; 910907

DR   Cosmic; 913312

DR   Cosmic; 1609543

DR   Cosmic; 2434093

DR   Cosmic-CLP; 910907

DR   GDSC; 910907

DR   GEO; GSM206550

DR   GEO; GSM621893

DR   GEO; GSM784708

DR   GEO; GSM887672

DR   GEO; GSM888764

DR   GEO; GSM1024415

DR   GEO; GSM1670506

DR   IGRhCellID; SW1990

DR   KCB; KCB 2012113YJ

DR   PRIDE; PXD003198

DR   TOKU-E; 3217

RX   PubMed=6871872;

RX   PubMed=15126341;

RX   PubMed=15688027;

RX   PubMed=18380791;

RX   PubMed=22460905;

RX   PubMed=25167228;

RX   PubMed=25485619;

RX   PubMed=25984343;

RX   PubMed=27259358;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=SW1990

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Doubling time: 72 hours (PubMed=25984343); 35.8 +- 4.4 hours (PubMed=27067801).

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Array-based CGH.

CC   Omics: Deep exome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,12

ST   D13S317: 8,12

ST   D16S539: 13

ST   D18S51: 13

ST   D21S11: 31

ST   D3S1358: 16

ST   D5S818: 12,13

ST   D7S820: 9,10

ST   D8S1179: 11,14

ST   FGA: 26

ST   Penta D: 11

ST   Penta E: 5,7

ST   TH01: 9.3

ST   TPOX: 8,9

ST   vWA: 17

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SW2

AC   CVCL_R777

SY   SW-2

DR   BTO; BTO:0005501

CC   From: Bernal S.D.; Dana-Farber Cancer Institute; Boston; USA.

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SW210.5

AC   CVCL_S185

RX   PubMed=11414198;

DI   NCIt; C4917; Small cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SW213

AC   CVCL_1E93

SY   SW-213; SW 213

RX   DOI=10.1007/978-1-4757-1647-4_2;

CC   From: Scott and White Clinic; Temple; Texas; USA.

DI   NCIt; C34447; Head and neck squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SW267

AC   CVCL_1E53

SY   SW-267; SW 267

RX   DOI=10.1007/978-1-4757-1647-4_2;

RX   PubMed=833871;

RX   PubMed=6935474;

CC   From: Scott and White Clinic; Temple; Texas; USA.

DI   NCIt; C5328; Extra-adrenal retroperitoneal paraganglioma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SW403

AC   CVCL_0545

SY   SW-403; SW 403

DR   BTO; BTO:0000033

DR   CLO; CLO_0009193

DR   CLO; CLO_0009214

DR   CLO; CLO_0009215

DR   EFO; EFO_0002366

DR   MCCL; MCC:0000446

DR   CLDB; cl4432

DR   ATCC; CCL-230

DR   BCRC; 60258

DR   BioSample; SAMN01821601

DR   BioSample; SAMN01821667

DR   BioSample; SAMN03473184

DR   CCLE; SW403_LARGE_INTESTINE

DR   CLS; 300350/p477_SW-403

DR   Cosmic; 724848

DR   Cosmic; 738937

DR   Cosmic; 876718

DR   Cosmic; 910908

DR   Cosmic; 934566

DR   Cosmic; 948128

DR   Cosmic; 948831

DR   Cosmic; 983731

DR   Cosmic; 986019

DR   Cosmic; 995394

DR   Cosmic; 1071893

DR   Cosmic; 1176594

DR   Cosmic; 1184097

DR   Cosmic; 1187322

DR   Cosmic; 1310938

DR   Cosmic; 1312315

DR   Cosmic; 1479587

DR   Cosmic; 1609502

DR   Cosmic; 1676749

DR   Cosmic; 1708408

DR   Cosmic; 1805267

DR   Cosmic; 2302016

DR   Cosmic-CLP; 910908

DR   DSMZ; ACC-294

DR   ECACC; 87071008

DR   GDSC; 910908

DR   GEO; GSM206551

DR   GEO; GSM513923

DR   GEO; GSM514310

DR   GEO; GSM741263

DR   GEO; GSM887673

DR   GEO; GSM888765

DR   GEO; GSM1346889

DR   GEO; GSM1374923

DR   GEO; GSM1374924

DR   GEO; GSM1448194

DR   IGRhCellID; SW403

DR   KCLB; 10230

RX   PubMed=327080;

RX   PubMed=1000501;

RX   PubMed=6582512;

RX   PubMed=7104989;

RX   PubMed=10737795;

RX   PubMed=11226274;

RX   PubMed=20606684;

RX   PubMed=22460905;

RX   PubMed=24755471;

RX   PubMed=25485619;

RX   PubMed=25926053;

WW   http://www.pawefish.path.cam.ac.uk/ColonCellLineDescriptions/SW403.html

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: KuDOS 95 cell line panel.

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Doubling time: ~40-50 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; CLS; DSMZ; ECACC; KCLB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,13

ST   D13S317: 13

ST   D16S539: 10,12

ST   D18S51: 17

ST   D21S11: 28,29

ST   D3S1358: 15

ST   D5S818: 11

ST   D7S820: 8,9

ST   D8S1179: 11 (CLS)

ST   D8S1179: 11,14 (PubMed=25877200)

ST   FGA: 19

ST   Penta D: 9

ST   Penta E: 5

ST   TH01: 6

ST   TPOX: 8,9

ST   vWA: 14,18

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SW409

AC   CVCL_1E94

SY   SW-409; SW 409

RX   DOI=10.1007/978-1-4757-1647-4_2;

CC   From: Scott and White Clinic; Temple; Texas; USA.

DI   NCIt; C7359; Endometrial adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SW419

AC   CVCL_1E95

SY   SW-419; SW 419

RX   DOI=10.1007/978-1-4757-1647-4_2;

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Derived from metastatic site: Peritoneum.

DI   NCIt; C7700; Ovarian adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SW451

AC   CVCL_1E55

SY   SW-451; SW 451

RX   PubMed=833871;

CC   From: Scott and White Clinic; Temple; Texas; USA.

DI   NCIt; C4024; Esophageal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SW47

AC   CVCL_1E54

SY   SW-47; SW 47

RX   DOI=10.1007/978-1-4757-1647-4_2;

RX   PubMed=833871;

RX   PubMed=6244232;

RX   PubMed=6935474;

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Derived from metastatic site: Liver.

DI   NCIt; C9325; Adrenal cortex carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SW48

AC   CVCL_1724

SY   SW-48; SW 48

DR   BTO; BTO:0001535

DR   CLO; CLO_0009216

DR   EFO; EFO_0002367

DR   CLDB; cl4971

DR   ATCC; CCL-231

DR   BCRC; 60311

DR   BioSample; SAMN03470827

DR   BioSample; SAMN03471477

DR   CCLE; SW48_LARGE_INTESTINE

DR   ChEMBL-Cells; CHEMBL3307292

DR   ChEMBL-Targets; CHEMBL614055

DR   Cosmic; 687544

DR   Cosmic; 711258

DR   Cosmic; 870450

DR   Cosmic; 873705

DR   Cosmic; 876645

DR   Cosmic; 876707

DR   Cosmic; 887225

DR   Cosmic; 889527

DR   Cosmic; 909751

DR   Cosmic; 948122

DR   Cosmic; 948855

DR   Cosmic; 986000

DR   Cosmic; 995399

DR   Cosmic; 1043828

DR   Cosmic; 1057753

DR   Cosmic; 1122330

DR   Cosmic; 1132563

DR   Cosmic; 1132688

DR   Cosmic; 1175846

DR   Cosmic; 1184089

DR   Cosmic; 1184332

DR   Cosmic; 1374624

DR   Cosmic; 1466821

DR   Cosmic; 1479633

DR   Cosmic; 1552177

DR   Cosmic; 1571771

DR   Cosmic; 1609488

DR   Cosmic; 1676725

DR   Cosmic; 1708409

DR   Cosmic; 1805268

DR   Cosmic; 1995653

DR   Cosmic; 2036657

DR   Cosmic; 2052594

DR   Cosmic; 2302017

DR   Cosmic-CLP; 909751

DR   ECACC; 89012702

DR   GDSC; 909751

DR   GEO; GSM513924

DR   GEO; GSM514311

DR   GEO; GSM741252

DR   GEO; GSM827355

DR   GEO; GSM844713

DR   GEO; GSM887675

DR   GEO; GSM888767

DR   GEO; GSM1346890

DR   GEO; GSM1374925

DR   GEO; GSM1374926

DR   GEO; GSM1374927

DR   GEO; GSM1448165

DR   GEO; GSM1670507

DR   ICLC; HTL99020

DR   IGRhCellID; SW48

DR   NCBI_Iran; C480

DR   SKY/M-FISH/CGH; 2838

RX   CelloPub=CLPUB00337;

RX   DOI=10.1007/978-1-4757-1647-4_2;

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=1000501;

RX   PubMed=6652615;

RX   PubMed=7104989;

RX   PubMed=7459858;

RX   PubMed=8422623;

RX   PubMed=9000572;

RX   PubMed=9515795;

RX   PubMed=10612807;

RX   PubMed=10737795;

RX   PubMed=11314036;

RX   PubMed=11526487;

RX   PubMed=19927377;

RX   PubMed=20606684;

RX   PubMed=22460905;

RX   PubMed=24042735;

RX   PubMed=24755471;

RX   PubMed=25485619;

RX   PubMed=25926053;

RX   PubMed=25984343;

RX   PubMed=26537799;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.addexbio.com/productdetail?pid=373

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: EGFR genetic alteration cell panel (ATCC TCP-1027).

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Doubling time: 33 hours (PubMed=25984343).

CC   Microsatellite instability: Instable (MSI-high) (PubMed=9000572; ubMed=24042735; PubMed=25926053; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep glycome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; ECACC; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 9,10

ST   D13S317: 11,12

ST   D16S539: 11,13

ST   D18S51: 13

ST   D21S11: 28,31

ST   D3S1358: 13,14,15

ST   D5S818: 10,14

ST   D7S820: 9,10

ST   D8S1179: 13,14,15

ST   FGA: 20

ST   Penta D: 10

ST   Penta E: 12,13

ST   TH01: 6,9.3

ST   TPOX: 8

ST   vWA: 18,20,21 (ATCC)

ST   vWA: 18,20 (Cosmic-CLP; ECACC; PubMed=25877200)

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SW48 TP53(+/-)

AC   CVCL_HE26

SY   TP53 (+/-) SW48

RX   PubMed=19225112;

WW   https://www.horizondiscovery.com/human-tp53-sw48-cell-line-hd-r06-001

CC   Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 11998; TP53.

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1724 ! SW48

SX   Female

CA   Cancer cell line

//

ID   SW48 TP53(-/-)

AC   CVCL_HE27

SY   TP53 (-/-) SW48

RX   PubMed=19225112;

WW   https://www.horizondiscovery.com/human-tp53-sw48-cell-line-hd-103-004

CC   Knockout cell: Method=Homologous recombination; HGNC; 11998; TP53.

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_1724 ! SW48

SX   Female

CA   Cancer cell line

//

ID   SW480

AC   CVCL_0546

SY   SW-480; SW 480; SW480E

DR   BTO; BTO:0000038

DR   CLO; CLO_0009195

DR   CLO; CLO_0009217

DR   CLO; CLO_0009218

DR   EFO; EFO_0002083

DR   MCCL; MCC:0000447

DR   CLDB; cl4440

DR   CLDB; cl4441

DR   CLDB; cl4966

DR   ATCC; CCL-228

DR   BCRC; 60249

DR   BioSample; SAMN01821602

DR   BioSample; SAMN03481110

DR   CCLE; SW480_LARGE_INTESTINE

DR   CCRID; 3111C0001CCC000166

DR   CCRID; 3131C0001000700086

DR   CCRID; 3142C0001000000064

DR   ChEMBL-Cells; CHEMBL3307758

DR   ChEMBL-Cells; CHEMBL3308067

DR   ChEMBL-Targets; CHEMBL612544

DR   ChEMBL-Targets; CHEMBL613840

DR   CLS; 300302/p716_SW-480

DR   Cosmic; 709847

DR   Cosmic; 711272

DR   Cosmic; 716169

DR   Cosmic; 720332

DR   Cosmic; 875293

DR   Cosmic; 876719

DR   Cosmic; 887240

DR   Cosmic; 889536

DR   Cosmic; 902791

DR   Cosmic; 905006

DR   Cosmic; 913892

DR   Cosmic; 948827

DR   Cosmic; 983732

DR   Cosmic; 985652

DR   Cosmic; 990302

DR   Cosmic; 995393

DR   Cosmic; 1043829

DR   Cosmic; 1057764

DR   Cosmic; 1066212

DR   Cosmic; 1071888

DR   Cosmic; 1122332

DR   Cosmic; 1132573

DR   Cosmic; 1132693

DR   Cosmic; 1154645

DR   Cosmic; 1176589

DR   Cosmic; 1184095

DR   Cosmic; 1184328

DR   Cosmic; 1187323

DR   Cosmic; 1223149

DR   Cosmic; 1310935

DR   Cosmic; 1332007

DR   Cosmic; 1374642

DR   Cosmic; 1466822

DR   Cosmic; 1479588

DR   Cosmic; 1482524

DR   Cosmic; 1486130

DR   Cosmic; 1524329

DR   Cosmic; 1552183

DR   Cosmic; 1571768

DR   Cosmic; 1609479

DR   Cosmic; 1676750

DR   Cosmic; 1708398

DR   Cosmic; 1803951

DR   Cosmic; 2036653

DR   Cosmic; 2145577

DR   Cosmic; 2156941

DR   Cosmic; 2267318

DR   Cosmic; 2301547

DR   Cosmic; 2302018

DR   Cosmic; 2433752

DR   DSMZ; ACC-313

DR   ECACC; 87092801

DR   ENCODE; ENCBS211HGL

DR   ENCODE; ENCBS421AQW

DR   GEO; GSM206552

DR   GEO; GSM513930

DR   GEO; GSM514312

DR   GEO; GSM741258

DR   GEO; GSM784022

DR   GEO; GSM861349

DR   GEO; GSM861350

DR   GEO; GSM861351

DR   GEO; GSM861352

DR   GEO; GSM887674

DR   GEO; GSM888766

DR   GEO; GSM1346891

DR   GEO; GSM1374928

DR   GEO; GSM1374929

DR   GEO; GSM1374930

DR   GEO; GSM1448166

DR   GEO; GSM1670508

DR   ICLC; HTL99017

DR   IGRhCellID; SW480

DR   KCB; KCB 200848YJ

DR   KCLB; 10228

DR   NCBI_Iran; C506

DR   PRIDE; PXD000089

DR   PRIDE; PXD000230

DR   PRIDE; PXD002793

DR   PRIDE; PXD003708

DR   SKY/M-FISH/CGH; 2839

DR   SKY/M-FISH/CGH; 3982

DR   TOKU-E; 3233

DR   Wikidata; Q28472974

RX   PubMed=288927;

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=1000501;

RX   PubMed=1389533;

RX   PubMed=1778766;

RX   PubMed=3349466;

RX   PubMed=6582512;

RX   PubMed=7104989;

RX   PubMed=7459858;

RX   PubMed=8422623;

RX   PubMed=8895552;

RX   PubMed=9000147;

RX   PubMed=9000572;

RX   PubMed=9290701;

RX   PubMed=10612807;

RX   PubMed=10674020;

RX   PubMed=10737795;

RX   PubMed=10773689;

RX   PubMed=11226274;

RX   PubMed=11414198;

RX   PubMed=11526487;

RX   PubMed=19927377;

RX   PubMed=20606684;

RX   PubMed=22460905;

RX   PubMed=24042735;

RX   PubMed=24755471;

RX   PubMed=25485619;

RX   PubMed=25926053;

RX   PubMed=25984343;

RX   PubMed=26537799;

RX   PubMed=27987026;

RX   PubMed=28196595;

WW   http://www.pawefish.path.cam.ac.uk/ColonCellLineDescriptions/SW480.html

WW   http://www.addexbio.com/productdetail?pid=43

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-54.html

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Doubling time: 24 hours (PubMed=25984343); ~25-30 hours (DSMZ).

CC   Microsatellite instability: Stable (MSS) (PubMed=9000147; PubMed=10674020; PubMed=24042735; PubMed=25926053).

CC   Omics: Deep glycome analysis.

CC   Omics: Deep phosphoproteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: shRNA library screening.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'WE480' or 'WE-480' in PubMed=12761194.

CC   Misspelling: 'SW80' in ChEMBL CHEMBL613840 and CHEMBL3308067.

ST   Source(s): AddexBio; ATCC; CLS; DSMZ; ECACC; KCLB; PubMed=11416159; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 13,14

ST   D13S317: 12

ST   D16S539: 13

ST   D18S51: 13

ST   D21S11: 30,30.2

ST   D3S1358: 15

ST   D5S818: 13

ST   D7S820: 8

ST   D8S1179: 13

ST   FGA: 24

ST   Penta D: 9,15

ST   Penta E: 10

ST   TH01: 8

ST   TPOX: 11

ST   vWA: 16

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0547 ! SW620

SX   Male

CA   Cancer cell line

//

ID   SW480/5FUR

AC   CVCL_AU16

WW   https://www.mdanderson.org/education-and-research/resources-for-professionals/scientific-resources/core-facilities-and-services/characterized-cell-line-core-facility/services/cclc-list-to-distribute-updated.xlsx

CC   Selected for resistance to: ChEBI; CHEBI:46345; 5-fluorouracil (5-FU).

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0546 ! SW480

SX   Male

CA   Cancer cell line

//

ID   SW480/BEVA

AC   CVCL_AU17

WW   https://www.mdanderson.org/education-and-research/resources-for-professionals/scientific-resources/core-facilities-and-services/characterized-cell-line-core-facility/services/cclc-list-to-distribute-updated.xlsx

CC   Selected for resistance to: Bevacizumab (Avastin).

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0546 ! SW480

SX   Male

CA   Cancer cell line

//

ID   SW480/CMV-Luc

AC   CVCL_4Y13

SY   SW-480/CMV-Luc

DR   JCRB; NIHS0738

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0546 ! SW480

SX   Male

CA   Cancer cell line

//

ID   SW480/nkR

AC   CVCL_AT66

RX   Patent=US7989001;

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0546 ! SW480

SX   Male

CA   Cancer cell line

//

ID   SW480/nkS

AC   CVCL_AT65

RX   Patent=US7989001;

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0546 ! SW480

SX   Male

CA   Cancer cell line

//

ID   SW480/OXR

AC   CVCL_AU18

WW   https://www.mdanderson.org/education-and-research/resources-for-professionals/scientific-resources/core-facilities-and-services/characterized-cell-line-core-facility/services/cclc-list-to-distribute-updated.xlsx

CC   Selected for resistance to: ChEBI; CHEBI:31941; Oxaliplatin (Elotaxin; L-OHP).

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0546 ! SW480

SX   Male

CA   Cancer cell line

//

ID   SW480E

AC   CVCL_AT67

SY   SW480 E8

DR   KCLB; 60067

RX   Patent=US7989001;

RX   PubMed=1458472;

ST   Source(s): KCLB

ST   Amelogenin: X

ST   CSF1PO: 13,14

ST   D13S317: 12

ST   D3S1358: 15

ST   D5S818: 13

ST   D7S820: 8

ST   FGA: 24

ST   TH01: 8

ST   TPOX: 11

ST   vWA: 16

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0546 ! SW480

SX   Male

CA   Cancer cell line

//

ID   SW480R

AC   CVCL_AT68

SY   SW480 R2

RX   Patent=US7989001;

RX   PubMed=1458472;

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0546 ! SW480

SX   Male

CA   Cancer cell line

//

ID   SW489

AC   CVCL_1E89

SY   SW-489; SW 489

RX   PubMed=833871;

RX   PubMed=994214;

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Doubling time: 26 hours, at 10th passage (PubMed=994214).

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SW527

AC   CVCL_3799

SY   SW-527; SW 527

DR   CLO; CLO_0009219

DR   EFO; EFO_0005462

DR   ATCC; CRL-7940

DR   BioSample; SAMN03151930

DR   BioSample; SAMN03481115

DR   Cosmic; 1047713

DR   LINCS; 50046

RX   PubMed=288927;

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=20143388;

RX   PubMed=25485619;

WW   http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=SW527

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a SW480 derivative (PubMed=288927, PubMed=20143388).

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Omics: Deep RNAseq analysis.

CC   Omics: SNP array analysis.

ST   Source(s): ATCC; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 13,14

ST   D13S317: 12

ST   D16S539: 9,13

ST   D18S51: 13

ST   D21S11: 30,30.2

ST   D3S1358: 15,16

ST   D5S818: 13

ST   D7S820: 8

ST   D8S1179: 13

ST   FGA: 24

ST   Penta D: 9,15

ST   Penta E: 10

ST   TH01: 8

ST   TPOX: 11

ST   vWA: 16

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0546 ! SW480

SX   Male

CA   Cancer cell line

//

ID   SW534

AC   CVCL_1E56

SY   SW-534; SW 534

RX   PubMed=833871;

CC   From: Scott and White Clinic; Temple; Texas; USA.

DI   NCIt; C4044; Laryngeal squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SW579

AC   CVCL_3603

SY   SW-579; SW 579

DR   CLO; CLO_0009220

DR   ATCC; HTB-107

DR   BCRC; 60412

DR   CCLE; SW579_THYROID

DR   CCRID; 3111C0001CCC000264

DR   CCRID; 3131C0001000700125

DR   CLS; 300346/p467_SW-579

DR   Cosmic; 1005454

DR   Cosmic; 1006467

DR   Cosmic; 1017791

DR   Cosmic; 1041672

DR   Cosmic; 1094773

DR   Cosmic; 1339924

DR   GEO; GSM887676

DR   GEO; GSM888768

DR   GEO; GSM1374931

DR   GEO; GSM1374932

DR   IGRhCellID; SW579

DR   IZSLER; BS TCL 121

DR   KCB; KCB 201304YJ

RX   DOI=10.1016/B978-0-12-333530-2.50007-1;

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=22460905;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: KuDOS 95 cell line panel.

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; CLS

ST   Amelogenin: X

ST   CSF1PO: 13

ST   D13S317: 13

ST   D16S539: 11

ST   D18S51: 15,17,18

ST   D21S11: 29,31

ST   D3S1358: 15,18

ST   D5S818: 11

ST   D7S820: 8,9

ST   D8S1179: 11,13

ST   FGA: 21,24

ST   Penta D: 9,12

ST   Penta E: 11,12

ST   TH01: 8,9.3

ST   TPOX: 8,10

ST   vWA: 14,18

DI   NCIt; C46008; Thyroid gland squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SW594

AC   CVCL_1E57

SY   SW-594; SW 594

RX   PubMed=833871;

CC   From: Scott and White Clinic; Temple; Texas; USA.

DI   NCIt; C3043; Fibrosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SW598

AC   CVCL_F649

SY   SW-598; SW 598

DR   ATCC; CRL-2176

DR   BioSample; SAMN03151931

RX   PubMed=288927;

RX   PubMed=833871;

RX   PubMed=20143388;

WW   http://www.atcc.org/support/faqs/9e860/SW%20598%20SW598%20SW598%20ATCC%20CRL2176-1059.aspx

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=288927, PubMed=20143388).

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Discontinued: ATCC; CRL-2176; true.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 13,14

ST   D13S317: 12

ST   D16S539: 13

ST   D5S818: 13

ST   D7S820: 8

ST   TH01: 8

ST   TPOX: 11

ST   vWA: 16

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0546 ! SW480

SX   Male

CA   Cancer cell line

//

ID   SW608

AC   CVCL_F653

SY   SW-608; SW 608

DR   BioSample; SAMN03151932

RX   PubMed=288927;

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=288927, PubMed=20143388).

CC   From: Scott and White Clinic; Temple; Texas; USA.

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0546 ! SW480

SX   Male

CA   Cancer cell line

//

ID   SW613

AC   CVCL_F650

SY   SW-613; SW 613

DR   ATCC; CRL-2146

DR   BioSample; SAMN03151933

DR   ChEMBL-Cells; CHEMBL3307463

DR   ChEMBL-Targets; CHEMBL614945

RX   PubMed=288927;

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=288927, PubMed=20143388).

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Discontinued: ATCC; CRL-2146; true.

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0546 ! SW480

SX   Male

CA   Cancer cell line

//

ID   SW620

AC   CVCL_0547

SY   SW-620; SW 620; SW.620

DR   BTO; BTO:0000675

DR   CLO; CLO_0009196

DR   CLO; CLO_0009221

DR   EFO; EFO_0002368

DR   MCCL; MCC:0000448

DR   CLDB; cl4443

DR   CLDB; cl4444

DR   CLDB; cl4969

DR   ATCC; CCL-227

DR   BCRC; 60343

DR   BioSample; SAMN03481108

DR   CCLE; SW620_LARGE_INTESTINE

DR   CCRID; 3111C0001CCC000207

DR   CCRID; 3131C0001000700101

DR   CCRID; 3142C0001000000118

DR   ChEMBL-Cells; CHEMBL3307944

DR   ChEMBL-Targets; CHEMBL612262

DR   CLS; 300466/p859_SW-620

DR   Cosmic; 719676

DR   Cosmic; 724849

DR   Cosmic; 873706

DR   Cosmic; 875294

DR   Cosmic; 875900

DR   Cosmic; 876720

DR   Cosmic; 887243

DR   Cosmic; 889525

DR   Cosmic; 897460

DR   Cosmic; 905962

DR   Cosmic; 934561

DR   Cosmic; 948828

DR   Cosmic; 974248

DR   Cosmic; 983733

DR   Cosmic; 986020

DR   Cosmic; 990304

DR   Cosmic; 1071889

DR   Cosmic; 1092640

DR   Cosmic; 1122333

DR   Cosmic; 1154646

DR   Cosmic; 1175845

DR   Cosmic; 1176590

DR   Cosmic; 1183768

DR   Cosmic; 1184083

DR   Cosmic; 1187324

DR   Cosmic; 1219446

DR   Cosmic; 1223150

DR   Cosmic; 1305357

DR   Cosmic; 1310936

DR   Cosmic; 1312341

DR   Cosmic; 1466823

DR   Cosmic; 1479589

DR   Cosmic; 1524325

DR   Cosmic; 1552181

DR   Cosmic; 1609505

DR   Cosmic; 1676751

DR   Cosmic; 1708397

DR   Cosmic; 1995654

DR   Cosmic; 1998483

DR   Cosmic; 2156943

DR   Cosmic; 2302019

DR   Cosmic-CLP; 905962

DR   ECACC; 87051203

DR   GDSC; 905962

DR   GEO; GSM50192

DR   GEO; GSM50256

DR   GEO; GSM206553

DR   GEO; GSM513819

DR   GEO; GSM513867

DR   GEO; GSM514313

DR   GEO; GSM514314

DR   GEO; GSM741270

DR   GEO; GSM750800

DR   GEO; GSM784023

DR   GEO; GSM799335

DR   GEO; GSM799398

DR   GEO; GSM847163

DR   GEO; GSM887677

DR   GEO; GSM888769

DR   GEO; GSM1153405

DR   GEO; GSM1181305

DR   GEO; GSM1181343

DR   GEO; GSM1346892

DR   GEO; GSM1374933

DR   GEO; GSM1374934

DR   GEO; GSM1374935

DR   GEO; GSM1448212

DR   ICLC; HTL99015

DR   IGRhCellID; SW620

DR   LINCS; 50047

DR   KCB; KCB 201198YJ

DR   KCLB; 10227

DR   KCLB; 60068

DR   PRIDE; PXD000089

DR   PRIDE; PXD003708

DR   PRIDE; PXD004079

DR   SKY/M-FISH/CGH; 2806

DR   SKY/M-FISH/CGH; 5075

DR   Wikidata; Q28519412

RX   PubMed=288927;

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=1000501;

RX   PubMed=2041050;

RX   PubMed=6582512;

RX   PubMed=9290701;

RX   PubMed=10773689;

RX   PubMed=11226274;

RX   PubMed=11414198;

RX   PubMed=17088437;

RX   PubMed=19372543;

RX   PubMed=19927377;

RX   PubMed=20606684;

RX   PubMed=22460905;

RX   PubMed=23856246;

RX   PubMed=23933261;

RX   PubMed=24042735;

RX   PubMed=24755471;

RX   PubMed=25485619;

RX   PubMed=25926053;

RX   PubMed=26537799;

RX   PubMed=27397505;

RX   PubMed=27470641;

RX   PubMed=27807467;

RX   PubMed=27987026;

RX   PubMed=28196595;

WW   https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm

WW   https://strap.nci.nih.gov/celline_detail.php?sample_id=18

WW   http://www.pawefish.path.cam.ac.uk/ColonCellLineDescriptions/SW620.html

WW   http://www.addexbio.com/productdetail?pid=68

WW   http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/s/cell-lines-detail-333.html

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: MD Anderson Cell Lines Project.

CC   Part of: NCI60 cancer cell line panel.

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Doubling time: 20.4 hours (DTP).

CC   Microsatellite instability: Stable (MSS) (PubMed=24042735; PubMed=25926053; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep glycome analysis.

CC   Omics: Deep phosphoproteome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): ATCC; Cosmic-CLP; ECACC; KCLB; PubMed=11416159; PubMed=19372543; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 13,14

ST   D13S317: 12

ST   D16S539: 9,13

ST   D18S51: 13

ST   D19S433: 13

ST   D21S11: 30,30.2

ST   D2S1338: 17,24

ST   D3S1358: 16

ST   D5S818: 13

ST   D7S820: 8,9

ST   D8S1179: 13

ST   FGA: 24

ST   Penta D: 9,15

ST   Penta E: 10

ST   TH01: 8

ST   TPOX: 11

ST   vWA: 16

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

OI   CVCL_0546 ! SW480

SX   Male

CA   Cancer cell line

//

ID   SW620-Luc

AC   CVCL_J268

DR   JCRB; JCRB1399

DR   JCRB; NIHS0648

CC   Transfected with: UniProtKB; P08659; Firefly luciferase.

CC   Discontinued: JCRB; NIHS0648; true.

CC   Derived from metastatic site: Lymph node.

ST   Source(s): JCRB

ST   Amelogenin: X

ST   CSF1PO: 13,14

ST   D13S317: 12

ST   D16S539: 9

ST   D5S818: 13

ST   D7S820: 8,9

ST   TH01: 8

ST   TPOX: 11

ST   vWA: 16

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0547 ! SW620

SX   Male

CA   Cancer cell line

//

ID   SW620-OX

AC   CVCL_4V76

RX   PubMed=24761924;

CC   Selected for resistance to: ChEBI; CHEBI:31941; Oxaliplatin (Elotaxin; L-OHP).

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0547 ! SW620

SX   Male

CA   Cancer cell line

//

ID   SW620/L-OHP

AC   CVCL_4V77

RX   PubMed=20591218;

CC   Selected for resistance to: ChEBI; CHEBI:31941; Oxaliplatin (Elotaxin; L-OHP).

CC   Derived from metastatic site: Lymph node.

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0547 ! SW620

SX   Male

CA   Cancer cell line

//

ID   SW626

AC   CVCL_1725

SY   SW-626; SW 626

DR   BTO; BTO:0001881

DR   CLO; CLO_0009197

DR   CLO; CLO_0009222

DR   CLDB; cl4446

DR   ATCC; HTB-78

DR   BioSample; SAMN03472756

DR   BioSample; SAMN03472876

DR   ChEMBL-Cells; CHEMBL3308130

DR   ChEMBL-Targets; CHEMBL1075593

DR   Cosmic; 724882

DR   Cosmic; 844346

DR   Cosmic; 849608

DR   Cosmic; 867865

DR   Cosmic; 897437

DR   Cosmic; 909753

DR   Cosmic; 920358

DR   Cosmic; 948285

DR   Cosmic; 949229

DR   Cosmic; 1044244

DR   Cosmic; 1113284

DR   Cosmic; 1707572

DR   Cosmic; 2582804

DR   Cosmic-CLP; 909753

DR   ECACC; 91091203

DR   GDSC; 909753

DR   GEO; GSM186459

DR   GEO; GSM186460

DR   GEO; GSM313714

DR   GEO; GSM659406

DR   GEO; GSM784571

DR   GEO; GSM1670509

DR   KCB; KCB 2013039YJ

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=6582512;

RX   PubMed=10433623;

RX   PubMed=11314036;

RX   PubMed=23415752;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Caution: Although established from a surgical specimen from a cystadenocarcinoma of the ovary in a 46 year old female Caucasian, it now seems likely that it was established from an ovarian metastasis of a colonic carcinoma (PubMed=10433623).

CC   Derived from metastatic site: Ovary.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 11 (ATCC; PubMed=25877200)

ST   D13S317: 11,12 (Cosmic-CLP)

ST   D16S539: 11

ST   D18S51: 14

ST   D19S433: 14

ST   D21S11: 27,29

ST   D2S1338: 25

ST   D3S1358: 15,17

ST   D5S818: 12

ST   D7S820: 10,12 (ATCC; Cosmic-CLP)

ST   D7S820: 12 (PubMed=25877200)

ST   D8S1179: 11

ST   FGA: 21,23

ST   Penta D: 9,13

ST   Penta E: 7,11

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 17,18

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SW684

AC   CVCL_1726

SY   SW-684; SW 684

DR   CLO; CLO_0009198

DR   EFO; EFO_0002369

DR   ATCC; HTB-91

DR   BioSample; SAMN03472761

DR   ChEMBL-Cells; CHEMBL3308217

DR   ChEMBL-Targets; CHEMBL2366143

DR   CLS; 300422/p547_SW-684

DR   Cosmic; 684075

DR   Cosmic; 909754

DR   Cosmic; 923379

DR   Cosmic-CLP; 909754

DR   GDSC; 909754

DR   GEO; GSM185154

DR   GEO; GSM185155

DR   GEO; GSM1670510

DR   GEO; GSM1676320

DR   GEO; GSM1701653

DR   IGRhCellID; SW684

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=26351324;

RX   PubMed=27397505;

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): ATCC; CLS; Cosmic-CLP

ST   Amelogenin: X,Y

ST   CSF1PO: 12,13

ST   D13S317: 10,13

ST   D16S539: 11,13

ST   D18S51: 14,19

ST   D21S11: 30,31.2

ST   D3S1358: 15,18

ST   D5S818: 12

ST   D7S820: 7,10

ST   D8S1179: 14

ST   FGA: 20,22

ST   Penta D: 13

ST   Penta E: 14,19

ST   TH01: 6,9.3

ST   TPOX: 11

ST   vWA: 16,17

DI   NCIt; C3043; Fibrosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SW690

AC   CVCL_1E24

SY   SW-690; SW 690

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=994214;

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Doubling time: 34 hours, at 11th passage (PubMed=994214).

CC   Derived from metastatic site: Brain.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SW691

AC   CVCL_0L89

SY   SW-691; SW 691

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=3020539;

CC   From: Scott and White Clinic; Temple; Texas; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SW707

AC   CVCL_6230

SY   SW-707; SW 707

DR   CLS; 300351/NA

DR   Cosmic; 889528

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=1000501;

RX   PubMed=7459858;

CC   From: Scott and White Clinic; Temple; Texas; USA.

DI   NCIt; C9383; Rectal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SW73.2

AC   CVCL_J774

DR   ECACC; 93113021

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_4342 ! Y3-Ag 1.2.3

CA   Hybridoma

//

ID   SW732

AC   CVCL_F651

SY   SW-732; SW 732

DR   BioSample; SAMN03151934

RX   PubMed=288927;

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=288927, PubMed=20143388).

CC   From: Scott and White Clinic; Temple; Texas; USA.

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0546 ! SW480

SX   Male

CA   Cancer cell line

//

ID   SW733

AC   CVCL_F652

SY   SW-733; SW 733

DR   BioSample; SAMN03151935

RX   PubMed=288927;

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=6244232;

RX   PubMed=20143388;

WW   http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf

CC   Problematic cell line: Contaminated. Shown to be a SW480 (or SW620) derivative (PubMed=288927, PubMed=20143388).

CC   From: Scott and White Clinic; Temple; Texas; USA.

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

HI   CVCL_0546 ! SW480

SX   Male

CA   Cancer cell line

//

ID   SW742

AC   CVCL_3884

SY   SW-742; SW 742

DR   BTO; BTO:0002825

DR   NCBI_Iran; C146

RX   PubMed=1000501;

RX   PubMed=17254797;

CC   From: Scott and White Clinic; Temple; Texas; USA.

ST   Source(s): PubMed=17254797

ST   Amelogenin: X

ST   CSF1PO: 13

ST   D13S317: 12

ST   D16S539: 12

ST   D18S51: 13

ST   D21S11: 29

ST   D3S1358: 15,16

ST   D5S818: 13

ST   D7S820: 8,9

ST   D8S1179: 14

ST   FGA: 24

ST   TH01: 8

ST   TPOX: 11

ST   vWA: 16

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SW756

AC   CVCL_1727

SY   SW-756; SW 756

DR   CLO; CLO_0009223

DR   EFO; EFO_0002370

DR   ATCC; CRL-10302

DR   BioSample; SAMN03471299

DR   ChEMBL-Cells; CHEMBL3308790

DR   ChEMBL-Targets; CHEMBL1075594

DR   Cosmic; 724839

DR   Cosmic; 925359

DR   Cosmic; 1131522

DR   Cosmic; 1193032

DR   Cosmic-CLP; 724839

DR   GDSC; 724839

DR   GEO; GSM113867

DR   GEO; GSM253303

DR   GEO; GSM675739

DR   GEO; GSM685443

DR   GEO; GSM1670511

DR   IGRhCellID; SW756

DR   IGRhCellID; SW756GEO

RX   PubMed=833871;

RX   PubMed=3029760;

RX   PubMed=6935474;

RX   PubMed=7129487;

RX   PubMed=15531914;

RX   PubMed=27397505;

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Characteristics: Contains a complete HPV18 genome.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): ATCC; Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11

ST   D16S539: 12,13

ST   D5S818: 11,12

ST   D7S820: 10,12

ST   TH01: 9.3

ST   TPOX: 8

ST   vWA: 17

DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SW780

AC   CVCL_1728

SY   SW-780; SW 780

DR   CLO; CLO_0009199

DR   EFO; EFO_0002371

DR   ATCC; CRL-2169

DR   BioSample; SAMN03473242

DR   CCLE; SW780_URINARY_TRACT

DR   CCRID; 3131C0001001200025

DR   ChEMBL-Cells; CHEMBL3308468

DR   ChEMBL-Targets; CHEMBL1075595

DR   Cosmic; 687457

DR   Cosmic; 1285128

DR   Cosmic; 1285990

DR   Cosmic; 1819323

DR   Cosmic; 2037958

DR   Cosmic; 2050464

DR   Cosmic; 2057457

DR   Cosmic; 2444257

DR   Cosmic-CLP; 687457

DR   GDSC; 687457

DR   GEO; GSM827294

DR   GEO; GSM887678

DR   GEO; GSM888770

DR   GEO; GSM1374936

DR   GEO; GSM1574556

DR   GEO; GSM1670512

DR   IGRhCellID; SW780

RX   PubMed=833871;

RX   PubMed=6244232;

RX   PubMed=6744315;

RX   PubMed=7459858;

RX   PubMed=22460905;

RX   PubMed=24018021;

RX   PubMed=24367658;

RX   PubMed=25485619;

RX   PubMed=25997541;

RX   PubMed=27397505;

CC   Part of: BLA-40 bladder carcinoma cell line panel.

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: UBC-40 urothelial bladder cancer cell line index.

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: CNV analysis.

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 11,12

ST   D16S539: 9,11

ST   D18S51: 15

ST   D21S11: 29,30

ST   D3S1358: 16,18

ST   D5S818: 11,12

ST   D7S820: 9,10

ST   D8S1179: 13

ST   FGA: 19,20

ST   Penta D: 9

ST   Penta E: 12

ST   TH01: 6

ST   TPOX: 8

ST   vWA: 16,19

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SW80

AC   CVCL_1E58

SY   SW-80; SW 80

RX   DOI=10.1007/978-1-4757-1647-4_2;

RX   PubMed=833871;

CC   From: Scott and White Clinic; Temple; Texas; USA.

DI   NCIt; C3359; Rhabdomyosarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SW800

AC   CVCL_A684

SY   SW-800; SW 800

DR   Cosmic; 715816

DR   Cosmic; 1016883

DR   Cosmic; 2037959

DR   GEO; GSM1574555

RX   PubMed=833871;

RX   PubMed=6244232;

RX   PubMed=6744315;

RX   PubMed=6935474;

RX   PubMed=16885334;

RX   PubMed=24018021;

RX   PubMed=25997541;

RX   PubMed=26621286;

CC   Part of: UBC-40 urothelial bladder cancer cell line index.

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Omics: CNV analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

DI   NCIt; C4912; Bladder carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SW802

AC   CVCL_L214

SY   SW-802; SW 802

RX   PubMed=833871;

RX   PubMed=1000501;

CC   From: Scott and White Clinic; Temple; Texas; USA.

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SW837

AC   CVCL_1729

SY   SW-837; SW 837

DR   CLO; CLO_0009200

DR   CLO; CLO_0009224

DR   EFO; EFO_0002372

DR   CLDB; cl4447

DR   CLDB; cl4448

DR   CLDB; cl4972

DR   ATCC; CCL-235

DR   BioSample; SAMN03472312

DR   CCLE; SW837_LARGE_INTESTINE

DR   ChEMBL-Cells; CHEMBL3308361

DR   ChEMBL-Targets; CHEMBL1075596

DR   Cosmic; 724852

DR   Cosmic; 873707

DR   Cosmic; 909755

DR   Cosmic; 948839

DR   Cosmic; 983734

DR   Cosmic; 985589

DR   Cosmic; 986021

DR   Cosmic; 995397

DR   Cosmic; 1043830

DR   Cosmic; 1122334

DR   Cosmic; 1132696

DR   Cosmic; 1184090

DR   Cosmic; 1310943

DR   Cosmic; 1312316

DR   Cosmic; 1374627

DR   Cosmic; 1479571

DR   Cosmic; 1676728

DR   Cosmic; 1708404

DR   Cosmic; 1805269

DR   Cosmic; 1995655

DR   Cosmic; 2302020

DR   Cosmic-CLP; 909755

DR   ECACC; 91031104

DR   GDSC; 909755

DR   GEO; GSM817

DR   GEO; GSM206554

DR   GEO; GSM513925

DR   GEO; GSM514315

DR   GEO; GSM741265

DR   GEO; GSM827281

DR   GEO; GSM887679

DR   GEO; GSM888771

DR   GEO; GSM1346893

DR   GEO; GSM1374937

DR   GEO; GSM1448195

DR   GEO; GSM1670513

DR   ICLC; HTL99021

DR   IGRhCellID; SW837

DR   JCRB; JCRB9115

DR   NCBI_Iran; C510

DR   SKY/M-FISH/CGH; 2849

RX   PubMed=1000501;

RX   PubMed=6652615;

RX   PubMed=7104989;

RX   PubMed=10612807;

RX   PubMed=10737795;

RX   PubMed=11226274;

RX   PubMed=19927377;

RX   PubMed=20606684;

RX   PubMed=22460905;

RX   PubMed=24755471;

RX   PubMed=25485619;

RX   PubMed=25926053;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://www.pawefish.path.cam.ac.uk/ColonCellLineDescriptions/SW837.html

WW   http://tcpaportal.org/mclp/

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: FGFR genetic alteration cell panel (ATCC TCP-1034).

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; ECACC; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 13

ST   D16S539: 12

ST   D18S51: 17

ST   D21S11: 28,31.2

ST   D3S1358: 18

ST   D5S818: 12

ST   D7S820: 9,12

ST   D8S1179: 8,14

ST   FGA: 25

ST   Penta D: 9,11

ST   Penta E: 11,12

ST   TH01: 9.3

ST   TPOX: 8,9

ST   vWA: 15,16

DI   NCIt; C9383; Rectal adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SW839

AC   CVCL_3604

SY   SW-839; SW 839

DR   ATCC; HTB-49

DR   BioSample; SAMN03472746

DR   IZSLER; BS TCL 219

RX   PubMed=6244232;

RX   PubMed=6935474;

RX   PubMed=7459858;

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Discontinued: ATCC; HTB-49; true.

ST   Source(s): ATCC

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 11,13

ST   D16S539: 11,12

ST   D5S818: 12

ST   D7S820: 10

ST   TH01: 9.3,10

ST   TPOX: 9,11

ST   vWA: 15,17

DI   NCIt; C4033; Clear cell renal cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SW843

AC   CVCL_1E59

SY   SW-843; SW 843

RX   PubMed=833871;

CC   From: Scott and White Clinic; Temple; Texas; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SW850

AC   CVCL_A424

SY   SW-850; SW 850

DR   Cosmic; 736278

DR   Cosmic; 933518

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=1906154;

RX   PubMed=9472115;

RX   PubMed=25997541;

RX   PubMed=26621286;

CC   Part of: UBC-40 urothelial bladder cancer cell line index.

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Omics: SNP array analysis.

CC   Caution: Considered by PubMed=25997541 to be a bladder carcinoma cell line. Status is uncertain as other publications mention is a being a pancreatic adenocarcinoma cell line.

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SW872

AC   CVCL_1730

SY   SW-872; SW 872

DR   BTO; BTO:0003743

DR   CLO; CLO_0009201

DR   EFO; EFO_0002373

DR   ATCC; HTB-92

DR   BCRC; 60432

DR   BioSample; SAMN03472763

DR   ChEMBL-Cells; CHEMBL3308837

DR   ChEMBL-Targets; CHEMBL2366302

DR   CLS; 300405/p537_SW-872

DR   Cosmic; 684521

DR   Cosmic; 909756

DR   Cosmic; 923383

DR   Cosmic; 2009544

DR   Cosmic; 2307722

DR   Cosmic-CLP; 909756

DR   GDSC; 909756

DR   GEO; GSM185156

DR   GEO; GSM185157

DR   GEO; GSM482514

DR   GEO; GSM1543668

DR   GEO; GSM1543669

DR   GEO; GSM1670514

DR   IGRhCellID; SW872

DR   IZSLER; BS TCL 119

DR   NCBI_Iran; C638

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=22911243;

RX   PubMed=24726063;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

ST   Source(s): ATCC; CLS; Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 10

ST   D13S317: 11

ST   D16S539: 9,12

ST   D18S51: 12,16

ST   D21S11: 27,31.2

ST   D3S1358: 16

ST   D5S818: 12,13

ST   D7S820: 8,11

ST   D8S1179: 12,15

ST   FGA: 21.2,23

ST   Penta D: 9,10

ST   Penta E: 5,10

ST   TH01: 8,10

ST   TPOX: 8,11

ST   vWA: 17

DI   NCIt; C3194; Liposarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SW897

AC   CVCL_1E60

SY   SW-897; SW 897

RX   PubMed=833871;

CC   From: Scott and White Clinic; Temple; Texas; USA.

DI   NCIt; C3224; Melanoma

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Cancer cell line

//

ID   SW900

AC   CVCL_1731

SY   SW-900; SW 900

DR   BTO; BTO:0004611

DR   CLO; CLO_0009202

DR   EFO; EFO_0002374

DR   ATCC; HTB-59

DR   BioSample; SAMN03472972

DR   CCLE; SW900_LUNG

DR   ChEMBL-Cells; CHEMBL3308819

DR   ChEMBL-Targets; CHEMBL1075597

DR   Cosmic; 724879

DR   Cosmic; 933582

DR   Cosmic; 1071890

DR   Cosmic; 1176591

DR   Cosmic; 1608837

DR   Cosmic; 1995656

DR   Cosmic; 2060528

DR   Cosmic-CLP; 724879

DR   GDSC; 724879

DR   GEO; GSM63352

DR   GEO; GSM784255

DR   GEO; GSM827522

DR   GEO; GSM887680

DR   GEO; GSM888772

DR   GEO; GSM1670515

DR   IGRhCellID; SW900

DR   KCLB; 30059

RX   PubMed=327080;

RX   PubMed=833871;

RX   PubMed=6935474;

RX   PubMed=7459858;

RX   PubMed=7736387;

RX   PubMed=22460905;

RX   PubMed=24135919;

RX   PubMed=25485619;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep phosphoproteome analysis.

CC   Omics: Deep proteome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

ST   Source(s): ATCC; Cosmic-CLP; KCLB; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11

ST   D13S317: 8

ST   D16S539: 11

ST   D18S51: 19

ST   D21S11: 29,31

ST   D3S1358: 14

ST   D5S818: 11

ST   D7S820: 11,12

ST   D8S1179: 11,16

ST   FGA: 21,23

ST   Penta D: 9,12

ST   Penta E: 14,15

ST   TH01: 8

ST   TPOX: 11

ST   vWA: 16

DI   NCIt; C3493; Squamous cell lung carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SW948

AC   CVCL_0632

SY   SW-948; SW 948

DR   BTO; BTO:0001534

DR   CLO; CLO_0009203

DR   CLO; CLO_0009225

DR   CLO; CLO_0009226

DR   EFO; EFO_0002375

DR   CLDB; cl4449

DR   ATCC; CCL-237

DR   BCRC; 60318

DR   BioSample; SAMN03473187

DR   CCLE; SW948_LARGE_INTESTINE

DR   ChEMBL-Cells; CHEMBL3308131

DR   ChEMBL-Targets; CHEMBL1075598

DR   CLS; 300347/p455_SW-948

DR   Cosmic; 724850

DR   Cosmic; 876721

DR   Cosmic; 909757

DR   Cosmic; 934565

DR   Cosmic; 948832

DR   Cosmic; 995395

DR   Cosmic; 1043831

DR   Cosmic; 1184094

DR   Cosmic; 1223151

DR   Cosmic; 1310941

DR   Cosmic; 1312317

DR   Cosmic; 1466824

DR   Cosmic; 1479599

DR   Cosmic; 1609501

DR   Cosmic; 1676730

DR   Cosmic; 1708413

DR   Cosmic; 1803952

DR   Cosmic; 1995657

DR   Cosmic; 2302021

DR   Cosmic-CLP; 909757

DR   DSMZ; ACC-326

DR   ECACC; 91030714

DR   GDSC; 909757

DR   GEO; GSM206555

DR   GEO; GSM513926

DR   GEO; GSM514316

DR   GEO; GSM741243

DR   GEO; GSM784024

DR   GEO; GSM887681

DR   GEO; GSM888773

DR   GEO; GSM1346894

DR   GEO; GSM1374938

DR   GEO; GSM1374939

DR   GEO; GSM1448213

DR   GEO; GSM1670516

DR   IGRhCellID; SW948

DR   NCBI_Iran; C499

RX   PubMed=1000501;

RX   PubMed=7104989;

RX   PubMed=10737795;

RX   PubMed=12584437;

RX   PubMed=20606684;

RX   PubMed=22460905;

RX   PubMed=24042735;

RX   PubMed=24755471;

RX   PubMed=25485619;

RX   PubMed=25926053;

RX   PubMed=26537799;

RX   PubMed=27397505;

CC   Part of: Cancer Cell Line Encyclopedia (CCLE) project.

CC   Part of: KuDOS 95 cell line panel.

CC   Part of: PI3K genetic alteration cell panel (ATCC TCP-1028).

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Doubling time: 2-4 days (DSMZ).

CC   Microsatellite instability: Stable (MSS) (PubMed=24042735; PubMed=25926053; Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep glycome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: SNP array analysis.

CC   Omics: Transcriptome analysis.

CC   Misspelling: 'SW984' in Cosmic 1184094.

ST   Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; ECACC; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 12

ST   D13S317: 10,11

ST   D16S539: 11,12

ST   D18S51: 19

ST   D21S11: 25.2,29

ST   D3S1358: 16

ST   D5S818: 11

ST   D7S820: 9,11

ST   D8S1179: 12,14

ST   FGA: 24

ST   Penta D: 12

ST   Penta E: 13

ST   TH01: 6,9.3

ST   TPOX: 8,11

ST   vWA: 16,18

DI   NCIt; C4349; Colon adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SW954

AC   CVCL_1732

SY   SW-954; SW 954

DR   CLO; CLO_0009204

DR   EFO; EFO_0002376

DR   ATCC; HTB-117

DR   BioSample; SAMN03471097

DR   ChEMBL-Cells; CHEMBL3307461

DR   ChEMBL-Targets; CHEMBL614943

DR   Cosmic; 924247

DR   Cosmic-CLP; 924247

DR   GDSC; 924247

DR   GEO; GSM1670517

DR   IGRhCellID; SW954

RX   PubMed=27397505;

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): ATCC; Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 9,11

ST   D16S539: 11

ST   D5S818: 11,12

ST   D7S820: 11,13

ST   TH01: 8,9.3

ST   TPOX: 8

ST   vWA: 14,15

DI   NCIt; C4052; Vulvar squamous cell carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SW962

AC   CVCL_1733

SY   SW-962; SW 962

DR   CLO; CLO_0009205

DR   EFO; EFO_0002377

DR   ATCC; HTB-118

DR   BioSample; SAMN03471098

DR   ChEMBL-Cells; CHEMBL3307274

DR   ChEMBL-Targets; CHEMBL613530

DR   Cosmic; 909758

DR   Cosmic-CLP; 909758

DR   GDSC; 909758

DR   GEO; GSM1670518

DR   IGRhCellID; SW962

DR   IZSLER; BS TCL 211

RX   PubMed=327080;

RX   PubMed=6935474;

RX   PubMed=27397505;

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: DNA methylation analysis.

ST   Source(s): ATCC; Cosmic-CLP

ST   Amelogenin: X

ST   CSF1PO: 10,11

ST   D13S317: 11,14

ST   D16S539: 9,11

ST   D5S818: 12

ST   D7S820: 10,11

ST   TH01: 6,9.3

ST   TPOX: 11

ST   vWA: 15,17

DI   NCIt; C4866; Vulvar carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SW979

AC   CVCL_4057

SY   SW-979; SW 979

DR   Cosmic; 736279

DR   Cosmic; 922261

DR   Cosmic; 933520

RX   PubMed=833871;

RX   PubMed=6935474;

RX   PubMed=11169959;

RX   PubMed=12800145;

WW   http://www.pawefish.path.cam.ac.uk/PancCellLineDescriptions/SW-979.html

CC   From: Scott and White Clinic; Temple; Texas; USA.

DI   NCIt; C8294; Pancreatic adenocarcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Cancer cell line

//

ID   SW982

AC   CVCL_1734

SY   SW-982; SW 982

DR   CLO; CLO_0009206

DR   EFO; EFO_0002378

DR   ATCC; HTB-93

DR   BCRC; 60535

DR   BioSample; SAMN03471376

DR   BioSample; SAMN03472764

DR   CCRID; 3131C0001001200001

DR   ChEMBL-Cells; CHEMBL3308534

DR   ChEMBL-Targets; CHEMBL2366238

DR   CLS; 300404/p703_SW-982

DR   Cosmic; 909759

DR   Cosmic; 1933188

DR   Cosmic; 2009545

DR   Cosmic-CLP; 909759

DR   GDSC; 909759

DR   GEO; GSM1670519

DR   GEO; GSM1676321

DR   GEO; GSM1701654

DR   IGRhCellID; SW982

RX   PubMed=833871;

RX   PubMed=15038780;

RX   PubMed=25485619;

RX   PubMed=26351324;

RX   PubMed=27397505;

RX   PubMed=28196595;

WW   http://tcpaportal.org/mclp/

CC   Part of: MD Anderson Cell Lines Project.

CC   From: Scott and White Clinic; Temple; Texas; USA.

CC   Microsatellite instability: Stable (MSS) (Sanger).

CC   Omics: Deep exome analysis.

CC   Omics: Deep RNAseq analysis.

CC   Omics: DNA methylation analysis.

CC   Omics: Protein expression by reverse-phase protein arrays.

CC   Omics: SNP array analysis.

ST   Source(s): ATCC; CLS; Cosmic-CLP; PubMed=25877200

ST   Amelogenin: X

ST   CSF1PO: 11,12

ST   D13S317: 12,13 (ATCC; Cosmic-CLP; PubMed=25877200)

ST   D13S317: 8,12,13 (CLS)

ST   D16S539: 11,12

ST   D18S51: 16,18

ST   D21S11: 28,30

ST   D3S1358: 15

ST   D5S818: 11,13 (ATCC; CLS; Cosmic-CLP)

ST   D5S818: 13 (PubMed=25877200)

ST   D7S820: 9,11

ST   D8S1179: 11,14

ST   FGA: 21,24

ST   Penta D: 10,13

ST   Penta E: 13,15

ST   TH01: 9.3

ST   TPOX: 9,11

ST   vWA: 19,20

DI   NCIt; C3400; Synovial sarcoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   Swan 71

AC   CVCL_D855

SY   SWAN 71; Swan-71

RX   PubMed=19766308;

CC   Transfected with: HGNC; 11730; TERT.

OX   NCBI_TaxID=9606; ! Homo sapiens

CA   Telomerase immortalized cell line

//

ID   SWEIG007

AC   CVCL_E838

SY   SWEIG-H; SWEIG-4H; SWEIG; Sweig

DR   dbMHC; 49030

DR   ECACC; 88052037

DR   IHW; IHW9037

DR   IMGT/HLA; 11414

DR   PRIDE; PXD001205

RX   PubMed=25502872;

WW   http://bioinformatics.hsanmartino.it/ecbr/cl37.html

CC   Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.

CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).

CC   Omics: HLA class II peptidome analysis by proteomics.

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Male

CA   Transformed cell line

//

ID   Swiss SFME

AC   CVCL_6459

SY   Swiss Serum Free Mouse Embryo

DR   CLO; CLO_0009228

DR   ATCC; CRL-9391

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Spontaneously immortalized cell line

//

ID   Swiss-LAPA

AC   CVCL_0552

SY   Swiss-LAP-A

DR   MCCL; MCC:0000453

CC   Breed/subspecies: NIH Swiss.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0594 ! NIH 3T3

SX   Male

CA   Spontaneously immortalized cell line

//

ID   Swiss19

AC   CVCL_1Y75

SY   Swiss 19

DR   EFO; EFO_0006297

RX   PubMed=20200519;

CC   Breed/subspecies: Swiss albino.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0120 ! 3T3-Swiss albino

SX   Male

CA   Spontaneously immortalized cell line

//

ID   Swiss2

AC   CVCL_1Y76

SY   Swiss 2

DR   EFO; EFO_0006298

RX   PubMed=20200519;

CC   Breed/subspecies: Swiss albino.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0120 ! 3T3-Swiss albino

SX   Male

CA   Spontaneously immortalized cell line

//

ID   Swiss20

AC   CVCL_1Y77

SY   Swiss 20

RX   PubMed=20200519;

CC   Breed/subspecies: Swiss albino.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0120 ! 3T3-Swiss albino

SX   Male

CA   Spontaneously immortalized cell line

//

ID   Swiss22

AC   CVCL_1Y78

SY   Swiss 22

DR   EFO; EFO_0006299

RX   PubMed=20200519;

CC   Breed/subspecies: Swiss albino.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0120 ! 3T3-Swiss albino

SX   Male

CA   Spontaneously immortalized cell line

//

ID   Swiss27

AC   CVCL_1Y79

SY   Swiss 27

RX   PubMed=20200519;

CC   Breed/subspecies: Swiss albino.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0120 ! 3T3-Swiss albino

SX   Male

CA   Spontaneously immortalized cell line

//

ID   Swiss3

AC   CVCL_1Y80

SY   Swiss 3

DR   EFO; EFO_0006300

RX   PubMed=20200519;

CC   Breed/subspecies: Swiss albino.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0120 ! 3T3-Swiss albino

SX   Male

CA   Spontaneously immortalized cell line

//

ID   Swiss30

AC   CVCL_1Y81

SY   Swiss 30

RX   PubMed=20200519;

CC   Breed/subspecies: Swiss albino.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0120 ! 3T3-Swiss albino

SX   Male

CA   Spontaneously immortalized cell line

//

ID   Swiss38

AC   CVCL_1Y82

SY   Swiss 38

RX   PubMed=20200519;

CC   Breed/subspecies: Swiss albino.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0120 ! 3T3-Swiss albino

SX   Male

CA   Spontaneously immortalized cell line

//

ID   Swiss5

AC   CVCL_1Y83

SY   Swiss 5

DR   EFO; EFO_0006301

RX   PubMed=20200519;

CC   Breed/subspecies: Swiss albino.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0120 ! 3T3-Swiss albino

SX   Male

CA   Spontaneously immortalized cell line

//

ID   Swiss8

AC   CVCL_1Y84

SY   Swiss 8

DR   EFO; EFO_0006302

RX   PubMed=20200519;

CC   Breed/subspecies: Swiss albino.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0120 ! 3T3-Swiss albino

SX   Male

CA   Spontaneously immortalized cell line

//

ID   Swiss9

AC   CVCL_1Y85

SY   Swiss 9

DR   EFO; EFO_0006303

RX   PubMed=20200519;

CC   Breed/subspecies: Swiss albino.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_0120 ! 3T3-Swiss albino

SX   Male

CA   Spontaneously immortalized cell line

//

ID   SWLA1

AC   CVCL_2725

DR   CLO; CLO_0009229

DR   ATCC; HB-12559

RX   Patent=US6231857;

CC   Monoclonal antibody target: Streptococcus mutans cell surface lipooligosaccharide or lipopolysaccharide.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   SWLA2

AC   CVCL_2726

DR   CLO; CLO_0009230

DR   ATCC; HB-12560

RX   Patent=US6231857;

CC   Monoclonal antibody target: Streptococcus mutans cell surface lipooligosaccharide or lipopolysaccharide.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   SWLA3

AC   CVCL_2727

DR   CLO; CLO_0009231

DR   ATCC; HB-12558

RX   Patent=US6231857;

CC   Monoclonal antibody target: Streptococcus mutans cell surface lipooligosaccharide or lipopolysaccharide.

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_2155 ! P3/NS1/1-Ag4.1

CA   Hybridoma

//

ID   SwR-100

AC   CVCL_DD10

SY   SwR

RX   Patent=US5272070;

RX   PubMed=2105319;

RX   PubMed=2267628;

RX   PubMed=2521484;

CC   Selected for resistance to: ChEBI; CHEBI:9367; Swainsonine (Sw).

OX   NCBI_TaxID=10029; ! Cricetulus griseus

HI   CVCL_0214 ! CHO-K1

SX   Female

CA   Spontaneously immortalized cell line

//

ID   SWR/J.Li

AC   CVCL_S360

DR   ATCC; CRL-6457

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6457; true.

CC   Breed/subspecies: SWR/J.

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_6460 ! SWR/J.We

CA   Finite cell line

//

ID   SWR/J.We

AC   CVCL_6460

DR   CLO; CLO_0009232

DR   ATCC; CRL-6458

CC   Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).

CC   Discontinued: ATCC; CRL-6458; true.

CC   Breed/subspecies: SWR/J.

OX   NCBI_TaxID=10090; ! Mus musculus

OI   CVCL_S360 ! SWR/J.Li

CA   Finite cell line

//

ID   SWT

AC   CVCL_S951

RX   PubMed=4760587;

CC   Group: Fish cell line.

OX   NCBI_TaxID=8084; ! Xiphophorus hellerii

SX   Sex undetermined

CA   Spontaneously immortalized cell line

//

ID   SWS-26

AC   CVCL_IW65

DR   Cosmic; 1312194

RX   PubMed=20106510;

DI   NCIt; C4908; Ovarian carcinoma

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SWT-1

AC   CVCL_4W76

RX   PubMed=8760591;

CC   Doubling time: 16.4 +- 2.2 hours (PubMed=8760591).

DI   NCIt; C8715; Rhabdoid tumor of the kidney

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SWT-2

AC   CVCL_4W77

RX   PubMed=8760591;

CC   Doubling time: 18.7 +- 1.9 hours (PubMed=8760591).

CC   Derived from metastatic site: Pleural effusion.

DI   NCIt; C8715; Rhabdoid tumor of the kidney

OX   NCBI_TaxID=9606; ! Homo sapiens

SX   Female

CA   Cancer cell line

//

ID   SX10

AC   CVCL_S163

RX   PubMed=7528891;

RX   PubMed=11133995;

CC   Breed/subspecies: C3H/He.

DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_S164 ! SR-1 [Mouse mammary carcinoma]

SX   Female

CA   Cancer cell line

//

ID   SX9

AC   CVCL_D700

SY   SX-9

RX   PubMed=7528891;

RX   PubMed=9582343;

CC   Breed/subspecies: C3H/He.

DI   NCIt; C21678; Malignant neoplasms of the mouse mammary gland

OX   NCBI_TaxID=10090; ! Mus musculus

HI   CVCL_S164 ! SR-1 [Mouse mammary carcinoma]

SX   Female

CA   Cancer cell line

//

ID   SXC1

AC   CVCL_D677

SY   SXC-1; SXC 1

DR   BCRJ; 0230

RX   PubMed=2145365;

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_3411 ! P3X63Ag8

CA   Hybridoma

//

ID   SXC2

AC   CVCL_J096

SY   SXC-2; SXC 2

RX   PubMed=2145365;

OX   NCBI_TaxID=10090; ! Mus musculus

OX   NCBI_TaxID=10116; ! Rattus norvegicus

HI   CVCL_3411 ! P3X63Ag8

CA   Hybridoma

//

ID   SYF

AC   CVCL_6461

DR   CLO; CLO_0009233

DR   ATCC; CRL-2459

RX   PubMed=10228160;

CC   Knockout cell: Method=KO mouse; MGI; MGI:95602; Fyn.

CC   Knockout cell: Method=KO mouse; MGI; MGI:98397; Src.

CC   Knockout cell: Method=KO mouse; MGI; MGI:99147; Yes1.

CC   Transfected with: UniProtKB; P00552; Transposon Tn5 neo.

CC   Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).

OX   NCBI_TaxID=10090; ! Mus musculus

CA   Transformed cell line


您正在向 biovector.net  发送关于产品 细胞株Cell Lines 103及完全培养基-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心http://www.biovector.net 的询问

点击“立即发送”后,我们将在1个工作日内与您取得联系。